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Stroke is the leading cause of long-term adult disability and the third leading cause of 
death in the United States.  More that 72% of stroke victims are over the age of 65, yet most 
studies utilize young animals.  Aged rats suffer exacerbated stroke volume and inflammation, as 
well as worsened functional outcome when compared to young adult rats.  While the blood brain 
barrier (BBB) remains intact with age, it becomes more susceptible to external factors.  BBB 
permeability in the penumbra appears acutely, 20 min after middle cerebral artery occlusion 
(MCAO) in aged rats.  Importantly, BBB permeability is earlier and more severe in aged animals 
and occurs before neuronal damage.  Interestingly, our permeability studies using a small 
vascular space marker indicated small, subtle, permeability changes in the contralateral 
hemisphere.  Permeability changes in the contralateral hemisphere were not found in young rats 
and were not found in aged rats when using a large vascular space marker (Evan’s blue).     
 The free radical theory of aging contends that age-related diseases result from 
accumulation of oxidative stress damage as a result of increased generation of reactive oxygen 
species (ROS) and decreased antioxidant enzyme activity.  Of particular interest are the 
NADPH oxidases (NOX1, NOX2, and NOX4), which have been implicated as a damaging 
source of ROS during the aging process.  However, the role of NADPH oxidase isoforms during 
the progression of cerebral ischemia in aged rats is poorly understood.  Apocynin, a NOX2 
inhibitor, reduces infarct volume, neuron death, activated microglia, and edema formation in 
young rodents following brain injury.  However, when administered to aged rats, apocynin 
significantly increased mortality and edema formation.  These results indicate an age-dependent 
difference in the mechanism of action of apocynin.   
 Our studies demonstrate that aged rats have significantly worse strokes both in gross 
size as well as structure as compared to young rats.  Aged rats consistently have worsened and 
prolonged functional impairment, exacerbated BBB permeability, increased neuronal damage, 
and intensified inflammatory cell infiltration post MCAO and reperfusion when compared to 
young adult rats.  Importantly, BBB permeability and increased oxidative stress markers were 
found in the contralateral hemisphere of aged rats after MCAO and reperfusion.  These findings 
provide evidence for a compensatory role of the contralateral hemisphere after stroke that can 
only be studied in aged animals.  Utilizing aged animals to study the mechanisms of brain injury 
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Stroke is the leading cause of long-term adult disability and the third leading cause of death in 
the United States.  Over 750,000 individuals suffered a stroke in 2005 with mortality in 143,579 
cases (Lloyd-Jones et al., 2009).  Figure 1.1 depicts the incidence of stroke increasing 
exponentially with age.  In fact, approximately 72% of stroke victims are over 65 years of age 
(Figure 1.1).  Moreover, due to the longer life span of females stroke burden is actually greater 
for women than men. 
 Age, in particular, has been identified as an independent predictor of outcome following 
cerebral ischemia, influencing several aspects of stroke pathophysiology including blood brain 
barrier (BBB) integrity.  The BBB acts as a regulatory interface between the systemic circulation 
and the brain parenchyma.  Disruption of this critical barrier during cerebral ischemia is 
associated with increased morbidity and mortality.  Morphological changes in the BBB, which 
occur during aging, make it more susceptible to injury. 
The only FDA-approved therapy for ischemic stroke is the i.v. administration of tissue 
plasminogen activator (tPA) which promotes thrombolysis of an embolic thrombus to reestablish 
cerebral blood flow.  However, indications for tPA administration are strict including a narrow 
time window of opportunity, limitations due to risk of hemorrhage and implications of possible 
neurotoxicity.  Consequently, less than 5 percent of stroke patients receive i.v. tPA thrombolysis 
treatment.  After a decade of searching for neuroprotective agents to treat stroke, no clinically 
applicable treatments have been approved.  These failures may be attributed to the disregard 
for two important variables: advanced age and blood-brain barrier integrity.  Age is the largest 
risk factor for stroke and has been largely ignored in experimental animal models of stroke.  The 
BBB preserves the neuronal microenvironment and thus protecting the integrity of this barrier 




Stroke and Animal MCAO Models  
As 87% of strokes are ischemic in nature, most stroke models utilize occlusion of the middle 
cerebral artery (MCA) which results in reduced cerebral blood flow to the striatum and cortex 
(Ponten et al., 1973; Garcia, 1984).  Several types of MCA occlusion (MCAO) models exist that 
produce either permanent (Tamura et al., 1981; Bederson et al., 1986) or transient (Longa et al., 
1989; Belayev et al., 1996) occlusion via chemical (Moyanova et al., 1998; Nikolova et al., 2009) 
or physical (Badan I et al., 2003; Liu et al., 2009; Yao et al., 2003; Yao et al., 2009; DiNapoli VA 
et al., 2006) approaches.  Chemical occlusion consists of administration of endothelin-1 which 
constricts the vessel to reduce blood flow (Moyanova et al., 1998; Nikolova et al., 2009).  
Physical occlusion can be achieved by lifting the MCA with a tungsten hook (Badan I et al., 
2003), photothrombotic occlusion (Yao et al., 2003; Yao et al., 2009) or through the use of a 
nylon suture to block the vessel (Liu et al., 2009).   
A more appropriate model utilizes a blood clot to create an ischemic stroke, followed by 
tPA administration to disrupt the clot and reperfuse tissue (Kudo et al., 1982;Kaneko et al., 
1985;DiNapoli VA et al., 2006).  Several advantages of a fibrin clot model include: more realistic 
reperfusion, ability to utilize thrombolytic therapy, and ability to screen for neuroprotectants that 
are effective in concert with tPA.  Investigations by well established research groups administer 
to rodents a tPA dosage of 10-20 times the therapeutic dose for humans (0.9 mg/kg).  At this 
supratherapeutic dose tPA has been shown to increase edema (Armstead WM et al., 2006) and 
excitoxicity (Parathath et al., 2006;Tsirka, 1997;Wang et al., 1998) which lead to neuron death.  
Young adult male rats are most commonly used to study stroke.  With the investigation 
of the role of estrogen levels in stroke outcome, the use of young adult female rats has been 
implemented with an ovariectomized group to study post-menopausal changes.  However, 
ovariectomy models only represent approximately 13% of women (Acosta et al., 2009).  
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Furthermore, a disparity exists with estrogen treatment where aged animals have worsened 
stroke volume (Selvamani and Sohrabji, 2008; Rosen CL et al., 2005) and young adult females 
have improved outcome (McCullough LD and Hurn PD, 2003).    
Utilization of an embolic model of MCAO and tPA reperfusion in aged reproductively 
senescent female rodents allows for the investigation of mechanisms underlying stroke 
pathophysiology and effects of thrombolysis in a clinically relevant model.  
Age & Stroke 
Aging affects every organ system in the body, including the vasculature. These changes have a 
compounding effect in relationship to deteriorated functional performance and increased 
prevalence of chronic diseases.  In the cerebral microcirculation, age is associated with 
decreased elastin and collagen (Grunnet, 1969), increased tortuosity (Hassler, 1965; Akima et 
al., 1986), and vascular thickening (Ay et al., 2005) causing impaired cerebral autoregulation.  
The ability to react to and secrete neurotransmitters such as dopamine (Freeman and Gibson, 
1987; Arai and Kinemuchi, 1988; Gerhardt et al., 2002), glutamate (Dawson, Jr. et al., 1989) 
and nerve growth factor (Gomez-Pinilla et al., 1989) become altered in the aged brain. 
Advanced age is associated with dysregulation of the nitric oxide/cyclic guanosine 
monophosphate (NO/cGMP) pathway (Chalimoniuk and Strosznajder, 1998), which under 
physiological conditions promotes angiogenesis, neurogenesis, axonal outgrowth, and synaptic 
plasticity (Truman et al., 1996; Koyano-Nakagawa et al., 1999; Bredt and Snyder, 1994).  In 
agreement with this, aging has been correlated with decreased expression of VEGF and 
impaired angiogenesis (Black et al., 1989; Rivard et al., 1999), as well as decreased 
neurogenesis and neuronal progenitor cells (Kempermann et al., 1998; Kuhn et al., 1996).  
Furthermore, aging is characterized by vulnerability to oxidative stress (Aliev et al., 2002; Li et 
al., 2005b; Floyd and Hensley, 2000), excitotoxic damage (Wozniak et al., 1991; Wheeler and 
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Ondo, 1986), apoptotic events (Hiona and Leeuwenburgh, 2004) and traumatic injury (Hoane et 
al., 2004) possibly causing the cortical atrophy seen with advanced age. 
Age is a risk factor predicting worsened functional performance (Lindner et al., 2003) 
and poor functional recovery (Rosen CL et al., 2005; Markus et al., 2005; Lindner et al., 2003; 
Zhang et al., 2005; Zhao et al., 2005).  Likewise, with every year of age, nearly a percent more 
penumbral tissue turns to infarction (Ay et al., 2005).  Age-related alterations in the 
microvasculature appear to be the cause of poor neuron viability and increased mortality 
associated with stroke (Rosen CL et al., 2005; Lindner et al., 2003; Zhang et al., 2005). 
Structure and Function of the Blood-Brain Barrier  
The BBB forms discrete microenvironments within the brain to support the optimal functioning of 
a diverse array of neurotransmitters (Abbott, 1987). With over 20 m2 of surface area, BBB 
endothelial cells serve as the physical interface between the systemic circulation and brain 
parenchyma (Butt et al., 1990).  The BBB is a semi-permeable membrane with unique 
characteristics that confer distinct properties that differentiate the BBB from peripheral 
capillaries, including a well-defined basement membrane, presence of tight junctions, absence 
of fenestrations, and close apposition to other brain cell types, including pericytes, astrocytes, 
microglia, and neurons (Hawkins et al., 2007a; Huber et al., 2001).  Several reviews detail the 
transport properties of the BBB as they pertain to both drug delivery and pathology (Ohtsuki and 
Terasaki, 2007; Pardridge, 2007; Hawkins et al., 2007b; Persidsky et al., 2006; Pan and Kastin, 
2004).  
Once considered a static, rigid wall, the BBB is now considered a dynamic, complex 
structure capable of rapid modulation and response to stimuli (Huber et al., 2001). The BBB is 
able to maintain and regulate brain homeostasis and compensate for fluctuations in the 
systemic circulation and increased metabolic functions within the brain as it functions like a 
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dynamic barrier.  The active nature of the BBB also has important implications for the 
development and progression of central nervous system diseases, including HIV encephalitis 
(Toborek et al., 2003), meningitis (Winkler et al., 2001), multiple sclerosis (Plumb et al., 2002), 
Alzheimer’s and Parkinson’s disease (Zlokovic, 2002;Ariga et al., 1998), epilepsy (Saija et al., 
1992), and stroke (Latour LL et al., 2004). Previous studies have shown that the BBB is 
responsive to external stimuli and systemic-based diseases (Brooks et al., 2005;Witt et al., 
2003;Huber et al., 2002). Viewing the endothelium of the blood-brain barrier as part of a larger, 
integrated functional unit (neurovascular unit) has opened up exciting avenues for translational 
and collaborative research in which the blood-brain barrier is viewed as susceptible to pathology 
and a potential therapeutic target.  
A particularly unique aspect of BBB structure is the presence of tight junctions (Figure 
1.2), which create a rate-limiting barrier to paracellular diffusion of solutes between adjacent 
endothelial cells.  The tight junction consists of the transmembrane proteins junctional adhesion 
molecule, occludin, and claudins, linked via accessory proteins including zonula occludens 
(ZO)-1 and -2 to the actin cytoskeleton.  ZO-1 is a cytoskeletal scaffolding protein that recruits 
the transmembrane proteins occludin and claudin-5.  Occludin and claudin-5 homotypically bind 
the adjacent endothelial cell to seal the paracellular pathway.  Altered protein expression of 
occludin and claudin reflect tight junctional changes indicative of increased paracellular 
permeability.  Claudin-5 is essential for tight junction formation and the decreased expression of 
occludin at the cytoskeleton indicates increased permeability.  The BBB possesses an 
‘epithelial-like’ resistance (1500–2000 Ω*cm2) to paracellular diffusion, which helps to maintain 
brain homeostasis (Crone and Christensen, 1981).   
Tight junctions are dynamic structures, in which multiple signaling pathways and factors 
regulate the expression, localization, and protein-protein interactions (Bazzoni and Dejana, 
2004;Harhaj and Antonetti, 2004). Studies have shown that changes in total expression and 
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subcellular localization of the tight junction proteins have been associated with alterations in 
paracellular permeability (Huber et al., 2001) and may play an important role in communicating 
the state of cell–cell contacts to the nucleus and participating in the regulation of growth, 
differentiation, and gene expression (Matter et al., 2005). 
Disruption of this critical barrier during cerebral ischemia is associated with increased 
morbidity and mortality. The time course of BBB disruption during stroke and its role in ischemia 
and reperfusion injury is poorly understood.  Morphological changes in the BBB, which occur 
with aging, make it more sensitive to insult. Activation of the barrier to ischemia is well studied; 
however, the role of aging in altering the dynamic properties and functionality of the BBB has 
direct implications for the majority of stroke victims. 
The Inflammation and Free Radical Theories of Aging Combined 
The free radical theory of aging (Harman D, 1994;Harman D, 1956) contends that as aging 
progresses oxidative stress ensues due to accumulation of reactive substances as by-products 
of metabolic processes and decreased activity of antioxidant enzymes.  This theory has been 
widely substantiated by findings of decreased antioxidant enzyme activity (Mayhan WG et al., 
2008;Abete P et al., 1999;Harvey BH and Nel A, 2003;Kolosova NG et al., 2006;Azhar S et al., 
1995;Carney JM et al., 1991;Azhar S et al., 1995;Reaven PD et al., 1999), increased reactive 
oxygen species (ROS) (Hamilton CA et al., 2002;park L et al., 2007;Hamilton et al., 2001), and 
accumulation of products of oxidative stress (Azhar S et al., 1995;Reaven PD et al., 
1999;Carney JM et al., 1991;Knight JA et al., 1987) with advanced age.  Also, a species life-
span directly correlates to its ability to adapt to and neutralize ROS formation (Cutler RG, 1991).  
  Accumulation of ROS and reactive nitrogen species (RNS) correlates with increased 
inflammatory processes (Chung et al., 2001;Reale et al., 2003;Rodriguez et al., 2007).  Nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB) responds to pro-oxidants by 
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activating pro-inflammatory cytokine gene expression (Chung et al., 2001;Salvioli et al., 2006).  
Likewise, the aging process correlates with a basal level of inflammation (Muller-Werdan, 
2007;Krabbe et al., 2004;Perry et al., 2007).  Known as the inflammatory hypothesis of aging, 
increased age is associated with increased interleukin-6 (IL-6) (Miller and Cappuccio, 
2007;Krabbe et al., 2004;Muller-Werdan, 2007;Chung et al., 2001), interferon-gamma (IFN-γ) 
(Rodriguez et al., 2007;Chung et al., 2001), tumor necrosis factor-alpha (TNFα) (Rodriguez et 
al., 2007;Krabbe et al., 2004;Siren et al., 1993;Chung et al., 2001), interleukin-1 (IL-1) (Chung et 
al., 2001), and transforming growth factor beta (TGF-β) (Chung et al., 2001).  The inflammation 
hypothesis of aging has become a widely known theory into the relationship between the co-
morbidity of aging and neurodegenerative diseases (Chung et al., 2001;Muller-Werdan, 
2007;Krabbe et al., 2004). 
 Pro-inflammatory cytokines can also induce formation of ROS (Madamanchi et al., 
2005).  In particular, TNFα has been shown to modulate NADPH oxidase to increase ROS 
production (Basuroy et al., 2008;St et al., 2008;Anilkumar N et al., 2008;Jung Y et al., 
2008;Guggilam et al., 2007;Chenevier-Gobeaux et al., 2006).  Thus, a positive feedback loop of 
inflammation and oxidative stress ensues.  While the aging body is able to keep the basal 
inflammation and oxidative stress under control under physiological conditions, an injury or 
pathogen could disrupt the balance and exacerbate damage. 
The Blood-Brian Barrier and Aging  
BBB disruption plays a prominent role in the progression and onset of several 
neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases, as a result of a 
damaged endothelial barrier (Ariga et al., 1998). Increased transport of circulating amyloid beta 
peptides across the BBB has been linked to increased age in nonhuman primates, potentially 
leading to development of Alzheimer’s disease (Mackic et al., 2002). The BBB remains intact 
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during aging; however, it becomes more susceptible to external factors. Changes in BBB 
composition in aged animals include alterations in lipid and protein composition (Mooradian and 
Smith, 1992;Mooradian, 1994), changes in nutrient transport (Shah and Mooradian, 1997), and 
decreased reactivity to β-adrenergic neurotransmitters (Mooradian, 1994). Results have also 
demonstrated changes in tight junction proteins with decreased occludin expression and 
increased ZO-1 expression in 24 month old rats as compared to 3 and 12 month old rats 
(Mooradian et al., 2003). 
The BBB expresses efflux proteins responsible for preventing toxic substances that gain 
entry into the brain from accumulating.  Two such proteins are P-glycoprotein (P-gp) and 
multidrug resistance associated protein (MRP).  P-gp acts as an active efflux pump by shuttling 
potentially toxic substances from the brain to the blood.  Decreased P-gp expression has been 
shown in Parkinson’s (Kortekaas et al., 2005;Bartels et al., 2008b) and Alzheimer’s diseases 
(Cirrito et al., 2005).  Aging has also been shown to decrease P-gp expression and function in 
rodents (Matsuoka et al., 1999;Rosati et al., 2003;Tsai et al., 2002) and humans (Bartels et al., 
2008a). 
Age affects several critical BBB parameters, and recent evidence suggests that altered 
tight junction protein expression in aged rats could disrupt the functional and structural integrity 
of the BBB.  In a recent report, both ipsilateral and contralateral hemispheres of aged rats had 
increased BBB permeability to sucrose (342 Da) 24 h after MCAO and reperfusion (Kelly et al., 
2009).  Often in stroke studies utilizing young animals, the contralateral hemisphere is either 
ignored or considered control.  However, previous clinical studies have observed changes in the 
contralateral hemisphere following stroke (Carey et al., 2002;Blank et al., 2003).  These results 
highlight a role for the contralateral hemisphere as a compensatory mechanism following stroke.  
Utilizing aged rodents in stroke models provides a unique opportunity to gain a better 
understanding of changes in the contralateral hemisphere following stroke.   
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The Neurovascular Unit 
The periendothelial accessory structures of the BBB include pericytes, astrocytes, neurons and 
a basal membrane.  Pericytes can contribute to the regulation of endothelial cell proliferation, 
survival, migration, differentiation and vascular branching (Hellstrom et al., 2001).  Astrocytes 
are glia that surround more than 99% of the BBB endothelium affecting its function and 
morphology (Beck et al., 1984;Arthur et al., 1987).  Astrocytes also serve as a scaffold for 
neurons and microvessels during development.  The basal lamina, lying between the capillaries 
and the rest of the neurovascular unit, provides support for cell attachment and migration, as 
well as preventing the passage of macromolecules into the brain parenchyma.  Neuronal 
involvement in the neurovascular unit remains unclear.  However, the ability of the brain to 
increase the blood supply to neuronally active areas suggests at least an indirect link between 
the neurons and the BBB.   
Glial cells, specifically astrocytes, are involved in BBB development and activation 
during stress (Abbott, 1987).  Transformation of astrocytes to the reactive phenotype is 
characterized by increased expression of GFAP (glial fibrillary acidic protein) (Stoll et al., 1998) 
which has been shown to be a biomarker of neuronal damage (O'Callaghan and Sriram, 2005).  
Following cerebral ischemia there is increased expression of GFAP (Petito et al., 1990;Kindy et 
al., 1992;Petito and Halaby, 1993).  Constitutive expression of GFAP is increased in 24 month 
old rodents, as well as 60-79 year old humans, in the cortex and hippocampus (Nichols et al., 
1993).  Sex steroids (estrogen, testosterone, and dihydrotestosterone) have been implicated in 
maintaining GFAP levels, the ramifications of this are a loss of plasticity correlated with aging 
(Schroeder E et al., 2003;Sapolsky, 1992;Day et al., 1993).  In aged animals, the astroglial and 
microglial activation, along with glial scarring is abnormally accelerated in pathological 
conditions (Popa-Wagner A et al., 2007;Badan I et al., 2003).   
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 Microglia exist in two forms: ramified and reactive.  Ramified microglia are present in the 
brain throughout life, while reactive microglia are found during nervous system damage (Giulian 
and Baker, 1986;Lin et al., 1998).  Following ischemic onset, microglia become activated within 
minutes (Gehrmann et al., 1995;Gehrmann et al., 1992;Banati et al., 1993) with peak activation 
at 2 weeks (Lin et al., 1998).  Microglia can release cytokines, chemokines and other neurotoxic 
agents which can cause inflammation and exacerbate injury.  However, microglia are also 
responsible for scavenging cellular debris and releasing growth factors (Sriram and 
O'Callaghan, 2005).  In aged animals microglia become activated faster in response to stroke 
than young adult animals (Popa-Wagner A et al., 2007;Badan I et al., 2003).  
Reactive Oxygen Species & Reactive Nitrogen Species 
Schematic representation of reactive oxygen and nitrogen species generation and breakdown 
appears in Figure 1.3.  Superoxide (O2
-) is formed by NADPH oxidases.  Superoxide is normally 
converted by superoxide dismutase (SOD) into H2O2.  When pathological conditions cause 
increased superoxide concentration (either by increased production or decreased metabolism) it 
reacts with nitric oxide (NO.) to form peroxynitrite (ONOO-).   
Hydrogen peroxide is thought to be mainly produced by the breakdown of superoxide by 
SOD.  However, NOX4 containing NADPH oxidase, xanthine oxidase, and glucose oxidase also 
produce hydrogen peroxide (Martyn KD et al., 2006;Ruiz-Gines JA et al., 2000;Cai H, 2005).  
Catalase and glutathione peroxidase reduce hydrogen peroxide into water and molecular 
oxygen.  Under pathological conditions, H2O2 production can overwhelm these enzymes.  
Hydrogen peroxide can spontaneously form hydroxyl radical or can react with myeloperoxidase 
(MPO) to produce hypochlorous acid (HOCl) or nitrogen dioxide radical (NO2
.) which can cause 
nitratrion of tyrosines (3-NO2




The effects of ROS on cerebral microvasculature  
The direct effects of superoxide on the vasculature have not been clearly defined, but many 
speculate that the effects are concentration dependent (Miller AA et al., 2006).  When 
superoxide is produced in excess, it reacts with the vasodilator nitric oxide, decreasing its 
bioavailability and therefore possibly causing vasoconstriction.  Peroxynitrite formation 
inactivates Mn-SOD (Guo W et al., 2003), and leads to peroxidation of lipids, protein oxidation 
and DNA damage (Chan PH, 2001).   
Hydrogen peroxide has been shown to cause cerebral vasodilation (Iida Y and Katusic 
ZS, 2000;Paravicini et al., 2004;Wei EP et al., 1996;Yang ZW et al., 1998b;You J et al., 2005).  
Dilation can also be caused by amelioration of contractions by angiotensin II (Miller AA et al., 
2005).  Hypochlorous acid (HOCl) can oxidize low-density lipoproteins (LDLs) which then get 
taken up by macrophages, build up in atherosclerotic plaques, and react with proteins to inhibit 
the synthesis of nitric oxide (Zhang C et al., 2003).  The 3-nitrotyrosine (3-NO2
.-Tyr) produced 
by the reaction of nitrogen dioxide radicals with tyrosine residues can lead to impaired protein 
catalysis and dysregulated tyrosine kinase pathways, as phosphorylation of tyrosine is 
prevented by nitrogen dioxide (Bigelow DJ, 2008).  
 Hydrogen peroxide has been shown to dose-dependently increase permeability (Kahles 
T et al., 2007).  Hydroxyl radical, being highly reactive, can damage nuclei and cell membranes 
which can directly impact the integrity of the BBB (Bonomini F et al., 2008).  Peroxynitrite 
exposure has been shown to decrease claudin-5 content (Haorah et al., 2005).  ROS have also 
been shown to redistribute occludin (Schreibelt et al., 2007;Lee et al., 2004) and ZO-1 (Lee et 
al., 2004).  The changes in these tight junction proteins cause dysregulation of the BBB allowing 
paracellular diffusion and therefore disruption of the homeostasis of the brain parenchyma.  
With most studies of BBB functional integrity looking at Evan’s blue extravasation, it is not 
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surprising that few studies show changes in permeability.  The passage of Evan’s blue bound to 
albumin into the brain parenchyma marks the entry of a 65,000 dalton molecule past the BBB.  
As the barrier is physiologically able to prevent passage of molecules more than 200 times 
smaller than albumin, the extravasation of evan’s blue into the brain marks irreparable damage 
to the integrity of the BBB.  The use of small vascular space markers, i.e. sucrose (342 daltons), 
allows investigation of small, possibly reparable, damage to the BBB, or alternately controlled 
areas in the integrity. 
NADPH Oxidases  
Several isoforms of NADPH oxidases are expressed in vascular cells.  While the NOX2 isoform 
is widely considered the predominant isoform, it is the least expressed isoform in the brain 
vasculature.  In the brain vasculature, NADPH oxidase isoform expression varies with NOX1 
being the most abundant, followed by NOX4 and lastly NOX2 (Ago et al., 2005).  The NOX1 
isoform of NADPH oxidase consists of an enzymatic subunit which complexes with p22phox.  
Cytosolic subunits NOX organizer 1 (NoxO1) and NOX activator 1 (NoxA1) are required for 
activation of NOX1 (Takeya R et al., 2003).  Conversely, the NOX4 isoform does not require 
activation by recruitment of cytosolic subunits and is thus constitutively active (Martyn KD et al., 
2006).  The NOX2 isoform consists of a membrane bound enzymatic subunit (gp91phox) 
complexed with p22phox.  Phosphorylation of p47phox recruits the complex of p47phox, 
p67phox and rac to the membrane, activating NOX2 (Bedard K and Krause K, 2007).  Both 
NOX1 and NOX2 isoforms require activation to produce superoxide.  However, the NOX4 
isoform constitutively produces hydrogen peroxide (H2O2) (Martyn KD et al., 2006). 
 NOX2 is widely considered the isoform of NADPH oxidase to cause oxidative damage 
after cerebral ischemia (Kahles T et al., 2007;Tang et al., 2007;Wang Q et al., 2006).  However, 
in several studies NOX2 has been shown to be unchanged not only between the genders (Miller 
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AA et al., 2007) despite a well known difference in stroke risk between women and men, but 
also in saphenous veins following heart failure (Dworakowski R et al., 2008).  In basilar arteries 
NOX1 mRNA expression is 2.4 fold higher in males than in females (Miller AA et al., 2007) 
which correlates to the higher stroke risk in men when compared to pre-menopausal women.  
The role of NOX1 in stroke pathology has yet to be studied.  In vitro studies have shown 
upregulated NOX4 after serum deprivation (Lassegue et al., 2001).  In vivo, permanent 
occlusion of the MCA resulted in increased NOX4 mRNA at 24 h (Vallet P et al., 2005;Badan I 
et al., 2003) whereas transient occlusion resulted in increased NOX4 at 6 h but not 24 h 
(McCann SK et al., 2008).  NOX4 was also found to be upregulated in the contralateral 
hemisphere 24 h post-MCAO (Badan I et al., 2003).  Finally, NOX4 was increased in the 
saphenous veins following heart failure compared to healthy controls (Dworakowski R et al., 
2008).  While NOX1 and NOX4 have been largely ignored in stroke research, evidence 
suggests they play an important role in the progression of ischemic damage. 
Modulation of NADPH oxidases   
Inhibition of NOX2 with apocynin has recently gained momentum as a therapeutic option for 
treatment of acute ischemic stroke (Tang et al., 2007;Wang Q et al., 2006;Kahles T et al., 2007) 
as studies demonstrate that administration of apocynin (5-50 mg/kg; i.p.) in young rodents prior 
to MCAO, attenuated superoxide production, infarct volume (Tang et al., 2007), neuronal death, 
activation of microglia (Wang Q et al., 2006) and edema formation (Kahles T et al., 2007).   
 In non-phagocytic cell culture, apocynin is not an inhibitor of NADPH oxidase (Heumuller 
S et al., 2008).  However, apocynin has been extensively used as a selective inhibitor of 
NADPH oxidase in studies utilizing both in vitro and in vivo methodologies.  Apocynin is 
activated by oxidation by peroxidases into products that have higher efficiencies with faster 
initiation of NADPH oxidase inhibition (Johnson et al., 2002).  The oxidation of apocynin forms a 
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radical (Kanegae et al., 2007).  Two of these radicals can form a apocynin dimer which can also 
be oxidized by myeloperoxidase and bind to a radical to become a trimer (Ximenes et al., 2007).  
The mechanism of NADPH oxidase inhibition by apocynin is thought to be the interaction of 
apocynin with a thiol group on the membrane bound subunit of NADPH oxidase which then 
prevents the recruitment of the cytosolic subunits and therefore prevents superoxide production 
(Stefanska and Pawliczak, 2008).  Apocynin, as well as the dimer and trimer, were found to be 
incapable of binding GSH (thiol group) (Ximenes et al., 2007).  The radical and dimer radical, 
however, did react with GSH (Ximenes et al., 2007).  Thus the radical forms of apocynin are 
probably the inhibitors of NADPH oxidase.  
In pathologic inflammatory conditions, MPO is elevated (Tsimikas, 2008). In particular, 
aged animals exhibit exacerbated inflammatory cell infiltration (DiNapoli VA et al., 2008) and 
worsened stroke volume, which produces increased MPO expression (Romanos et al., 2007).  
The positive correlation between MPO expression and apocynin activation suggests enhanced 
NOX2 inhibition with age.  Data gathered from young animals suggest that increased NOX2 
inhibition results in a favorable outcome.  In direct contrast, our data show that aged rats exhibit 
exacerbated edema formation and increased mortality (Kelly et al., 2009).  We conclude that 
inhibition of NOX2 exacerbates stroke injury in the aged rat and would be a poor choice for 
clinical treatment of stroke.  
Plumbagin is a specific inhibitor of NOX4 (Ding et al., 2005).  It has been shown to have 
anti-carcinogenic (Ahmad et al., 2008;Kuo et al., 2006;Thasni et al., 2008), anti-atherosclerotic 
(Sharma I et al., 1991) and anti-thromboembolic effects (Shen Z et al., 2003).  In a study 
utilizing cholesterol fed rabbits, subsequent oral dosing of plumbagin reduced LDL cholesterol, 
increased HDL cholesterol, and decreased plaque formation on the aortic wall (Sharma I et al., 
1991).  In breast cancer cells, decreased estrogen receptor signaling increases NF-κB 
expression (Ahmad et al., 2008).  NF-κB promotes cell survival by inducing Bcl-2 (an anti-
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apoptotic gene) (Wang et al., 2007) and upregulating the PI3K/AKT pathway (promotes 
autophagic cell death).  Plumbagin has been shown to inhibit the activation of NF-κB caused by 
TNF, IL-1β, okadaic acid, LPS, H2O2, phorbol myristate acetate, and cigarette smoke (Sandur et 
al., 2006).  Also, TNFα induced COX-2, MMP-9 and VEGF were attenuated with plumbagin 
treatment (Sandur et al., 2006).  To date, plumbagin has not been studied in ischemia.    
Angiotensin II (ANGII) can be actively metabolized in the cerebromicrovasulature (Zhou 
et al., 2006).  Recent evidence suggests that ANGII provides the link between synaptic activity 
and blood flow, also known as functional hyperemia (Kazama K et al., 2004).  ANGII has been 
shown to increase the expression of gp91phox (Imanishi et al., 2005), and the effects of ANGII 
can be reversed by ROS scavengers (Kazama K et al., 2004;Didion and Faraci, 2003), NADPH 
oxidase inhibitors (apocynin and gp91ds-tat) (Kazama K et al., 2004;Rodriguez-Pallares et al., 
2008;Didion and Faraci, 2003;Pendergrass et al., 2009) and the use of gp91phox-null mice 
(Kazama K et al., 2004).  Also, administration of AT1 (angiotensin II receptor subtype 1) 
antagonists prevents the increased ROS associated with increased ANGII (Rodriguez-Pallares 
et al., 2008;Imanishi et al., 2005).  Animal models of cerebral ischemia have shown that 
administration of AT1 receptor antagonists reduce the expression of NADPH oxidase, decrease 
lipid peroxidation, improve functional outcome and reduce stroke volume (Kusaka I et al., 
2004;Faure et al., 2008).  However, the use of ACE (angiotensin converting enzyme) inhibitors 
or AT2 (ANGII receptor subtype 2) receptor antagonists have been shown to worsen ischemic 
damage (Faure et al., 2008;Dalmay et al., 2001;Li et al., 2005a), suggesting the effects of ANGII 
acting at non-AT1 receptors is neuroprotective.  In patients receiving AT1 receptor antagonists 
for treatment of hypertension, a meta-analysis found a 13% reduction in cardiovascular 
morbidity and mortality which included cardiovascular death, stroke, and myocardial infarction 




Matrix Metalloproteinases and Tissue Plasminogen Activator  
Tissue plasminogen activator (tPA) is the only FDA approved treatment of ischemic stroke.  The 
object of tPA treatment is to break up the clot and reperfuse the tissue affected by the occlusion.  
While tPA does effectively lyse blood clots, its effectiveness is questioned due to the increased 
risk of hemorrhage and deleterious effects on the neurovascular unit associated with its use.  
However, at a dose of 5 mg/kg i.v., administered 2 h post MCAO, tPA decreases BBB 
permeability in both young adult and aged rats 24 h after embolic MCAO (DiNapoli VA et al., 
2008).  Furthermore, a recent study utilizing EEIIMD (a hexapeptide that binds non-thrombolytic 
sites on tPA) provides evidence that while some cortical damage could be due to non-
thrombolytic actions of tPA; largely, striatal and total stroke volume are not exacerbated by tPA 
(Tan et al., 2009).     
 During physiological conditions tPA is produced endogenously in the CNS during 
learning of complex motor tasks (Harris-White and Frautschy, 2005).  Extracellular matrix 
remodeling, vascular permeability and excitotoxicity are some of the deleterious effects of tPA 
that most likely occur during pathological increase in tPA production (Harris-White and 
Frautschy, 2005;Yepes et al., 2003).  tPA is a ligand for low density lipoprotein receptor-related 
protein (LRP).  Recently, the relationship between tPA and LRP has been implicated in the 
permeability of the BBB after an ischemic injury (An et al., 2008).  Both tPA (Yepes et al., 2003) 
and LRP (An et al., 2008) are upregulated after ischemic insult and inhibition of LRP (An et al., 
2008) decreases edema formation.  Specifically, tPA binds to LRP to phosphorylate Akt which 
activates NF-κB and increases the expression of MMP-9 (An et al., 2008;Wang et al., 
2003b;Herz and Strickland, 2001).   
Matrix metalloproteinases (MMPs) are a family of Ca2+ or Zn2+ containing 
endopeptidases that have three similar structural domains: an aminoterminal propeptide, a 
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catalytic metal-containing domain and a hemopexin-like domain at the carboxy-terminal end.  A 
subtype of MMPs is known as the gelatinases (MMP-2 and MMP-9) which are specialized for 
degrading basement membrane (i.e. laminin and hepran sulfate proteoglycans) and 
extracellular matrix (i.e. collagen IV and fibronectin) proteins (Uemura et al., 2001;Thrailkill et 
al., 2007).   Under physiological conditions, expression of MMPs remains low.  However, MMP 
expression can be upregulated by reactive oxygen species (Shin MH et al., 2008;Haorah et al., 
2007;Gasche et al., 2001).  During pathologies that involve increased oxidative stress, such as 
stroke, MMP-2 and MMP-9 can become upregulated (Nagel S et al., 2007;Gasche et al., 2001). 
The fact that tPA upregulates MMP-9 is widely accepted (Tsuji et al., 2005;Montaner et 
al., 2001b;Wang et al., 2003b;Sumii and Lo, 2002;Cuadrado et al., 2008).  The actions of tPA 
and MMP-9 are implicated in the hemorrhagic transformation that casts risk onto the use of tPA 
as a stroke treatment.  Over 24 h, administration of tPA is associated with a time and dose 
dependent increase in active MMP-9 (Wang et al., 2003b).  Inhibition of MMPs attenuated 
incidence of tPA induced cerebral hemorrhage (Sumii and Lo, 2002).  In a model of focal 
cerebral ischemia MMP inhibitors reduced hemorrhage and improved functional outcome after 
tPA administration (Tsuji et al., 2005).     
 MMP-9 is elevated after stroke (Zhao et al., 2006;Tsuji et al., 2005;Yepes et al., 
2003;Montaner et al., 2001b;Montaner et al., 2001a;Wang et al., 2003b;Gidday JM et al., 
2005;Sumii and Lo, 2002;Clark et al., 1997;Cuadrado et al., 2008;Gu et al., 2002) by the actions 
of inflammatory cytokines (Akool et al., 2003;Rosenberg et al., 1995;Jian and Rosenberg, 
2005;Harkness et al., 2000;Zhou et al., 2009) and free radicals (Jian and Rosenberg, 
2005;Akool et al., 2003;Tsuji et al., 2005;Haorah et al., 2007;Gu et al., 2002).  As early as 4 
hours (Gasche et al., 2001) and from 1 to 3 d post-cerebral ischemia MMP-9 is increased in the 
endothelial cells of the ischemic striatum and cortex (Zhao et al., 2006;Montaner et al., 
2001a;Jian and Rosenberg, 2005;Wang et al., 2003b;Gidday JM et al., 2005;Clark et al., 1997). 
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At later time points, 7 to 14 d, MMP-9 is increased in the penumbral neurons and astrocytes 
(Zhao et al., 2006).  MMP-2, while constitutively active, becomes upregulated several months 
after stroke (Montaner et al., 2001a;Clark et al., 1997).  Levels of MMP-2 are increased in 
patients with previous history of stroke (Montaner et al., 2001a).  Increased MMP-9 is 
associated with worsened neurological outcome (Montaner et al., 2001a), activation of 
macrophages (Haorah et al., 2007), degradation of BBB substrates (Tsuji et al., 
2005;Rosenberg et al., 1995;Haorah et al., 2007;Gidday JM et al., 2005;Asahi et al., 2001;Van 
and Libert, 2007;Gu et al., 2002) and BBB permeability (Rosenberg et al., 1995;Haorah et al., 
2007;Montaner et al., 2001b;Gidday JM et al., 2005;Asahi et al., 2001), increased inflammatory 
cell infiltration (Tsuji et al., 2005;Rosenberg et al., 1995;Montaner et al., 2001a), parenchymal 
damage (Tsuji et al., 2005;Gidday JM et al., 2005), edema formation (Tsuji et al., 2005;Haorah 
et al., 2007;Montaner et al., 2001b;Gidday JM et al., 2005) and hemorrhage (Montaner et al., 
2001b;Lee et al., 2007) after cerebral ischemia.   
Use of MMP knockout mice caused decreased BBB degradation (Yepes et al., 2003), 
specifically attenuation of ZO-1 degradation (Asahi et al., 2001) after brain injury.  MMP 
inhibitors have decreased capillary permeability (Rosenberg et al., 1995) and hemorrhage (Lee 
et al., 2007) after cerebral ischemia.  Finally, treatment with MMP-9 siRNA 60 min after MCAO 
resulted in significant reduction in mortality, infarct volume, edema formation, and functional 
outcome (Hu et al., 2009).  It has been suggested that MMPs could be a possible therapeutic 
target (Hu et al., 2009) or surrogate marker for stroke damage (Montaner et al., 2001a).  This 
may be possible if focusing on MMP-9 at early time points.  However, MMP-2 is associated with 
angiogenesis (Rosenberg et al., 1995) and MMPs in general have been shown to be active in 
tissue repair (Jian and Rosenberg, 2005).  Due to the beneficial effect of MMPs at late time 





As promising neuroprotectants screened in animal models fail to translate into clinically relevant 
stroke therapies, the need for better models becomes increasingly imperative.  In this review of 
the current literature we have discussed the role of aging and the blood-brain barrier in stroke 
pathophysiology.  Age is the largest risk factor for stroke; yet, an overwhelming majority of 
animal models continue to utilize young adult animals to understand the mechanisms and find 
therapies for cerebral ischemia.  Results from models utilizing aged animals are increasingly 
divergent from those in young adult animals.  This disparity suggests that age is an important 
and yet overlooked variable in the study of stroke mechanism and the search for clinically 
applicable therapies.     
 Blood-brain barrier functional and structural integrity is extremely important to 
maintaining the microenvironment of the brain.  Studies have focused on gross breakdown of 
BBB functional integrity.  Utilizing small vascular space markers has allowed fine changes in 
BBB dysregulation to be elucidated.  Investigation of subtle changes in BBB functional and 
structural integrity will give better insight into the time frame and mechanism of the 











Figure 1.2 Schematic representation of intercellular junction between two endothelial cells.  
Cerebral endothelial cells possess cadherins, JAM, and tight junctions.  However, the tight 
junction provides the cerebral endothelium with its unique phenotype.  Zona occludens serve 
as the cytoskeletal scaffolding for the transmembrane proteins claudin-5 and occluden, which 
forms the cell-to-cell junction.  Claudin 5 is essential for tight junction formation.  Occluden 
exists as a cytosolic or plasma membrane protein and location within the cell reflect changes 





Figure 1.3. Mechanisms of formation and breakdown of reactive oxygen species.  Schematic 






Early disruptions of the blood-brain barrier may contribute to 
exacerbated neuronal damage and prolonged functional recovery 
following stroke in aged rats 
 




















We examined the effects of age on stroke progression and outcome in order to explore the 
association between blood-brain barrier (BBB) disruption, neuronal damage, and functional 
recovery. Using middle cerebral artery occlusion (MCAO), young (3 months) and aged (18 
months) rats were assessed for BBB disruption at 20 min post-MCAO, and 24 h post-MCAO 
with tissue plasminogen activator induced reperfusion at 120 min. In addition, young and aged 
rats were assayed for functional recovery out to 14 d post-MCAO and reperfusion. Results 
showed that BBB disruptions in aged rats occurred early and increased nearly two-fold at both 
the 20 min and 24 h time points when compared to young animals. Neuronal damage in aged 
rats was increased two-fold as compared to young rats at 24 h, and differed qualitatively in the 
degree of inflammatory cell infiltration, hemorrhage and edema. No difference in neuronal 
damage was observed between young and aged rats at 20 min. Young and aged rats exhibited 
neurological deficits when compared to sham-controls out to 14 d following MCAO and 
reperfusion; however, aged rats exhibited more severe onset of deficits and prolonged recovery. 
Results indicate that aged rats suffer larger infarcts with increased BBB disruption, greater 
neuronal damage, and reduced functional recovery. Moreover, BBB disruption at 20 min post-
MCAO in aged rats, in the absence of significant neuronal damage, suggests a potential 
mechanism by which alteration in BBB functional integrity during stroke contributes to a greater 





Stroke is a disease of the elderly. Approximately 72% of people who suffer a stroke are over the 
age of 65, 25% of the population over the age of 75 will have a stroke, and the incidence of 
stroke more than doubles with each successive decade for people over the age of 55 (Lloyd-
Jones et al., 2009). Increased infarction volumes and altered physiologic response has been 
demonstrated in aged rodents following middle cerebral artery occlusion (MCAO) (Rosen CL et 
al., 2005; Sutherland et al., 1996; DiNapoli VA et al., 2006). Young male animals and 
filamentous methods of occlusion commonly utilized in laboratory investigations may not 
accurately represent the stroke patient, as these methods have consistently identified promising 
neuroprotective candidates that have failed in clinical trials (Gladstone DJ et al., 2002;Fisher, 
1999; Fisher and Ratan, 2003).  
 The disparity between laboratory models and clinical studies may be secondary to 
changes which occur in the blood-brain barrier (BBB). A number of morphological and functional 
changes to the BBB occur during the aging process, including remodeling of the extracellular 
matrix, decreased occludin expression, changes in lipid and protein composition (Burns EM et 
al., 1981; Mooradian AD, 1988; Mooradian and Meredith, 1992; Mooradian and Smith, 1992), 
alterations in nutrient and protein transport (Shah GN and Mooradian AD, 1997;Banks and 
Kastin, 1985; Kleine et al., 1993), and decreased reactivity to β-adrenergic neurotransmission 
(Mooradian, 1994). These alterations make the barrier more vulnerable to insult, such as 
ischemia. Cessation of cerebral blood flow and the subsequent lack of tissue oxygenation can 
lead to increased BBB permeability by a progressive loss of component antigens from the basal 
lamina and extracellular matrix, as well as alterations in endothelial cell-cell and cell-matrix 
interactions.  The active hypoxia/ischemia induced following a stroke stimulates the surface 
expression of adhesion molecules (Haring et al., 1996; Mao et al., 2000) and changes in integrin 
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expression (Wagener et al., 1997) in the first few hours. Activation of the BBB leads to 
endothelial dysfunction, characterized by increased permeability, extravasation of plasma 
components, and edema formation (Okada et al., 1996). What effect aging has in this process 
and how it may affect stroke outcome are not well characterized. 
 We utilized a clinically relevant model of stroke, based upon selective embolization of 
the middle cerebral artery (MCA) combined with recombinant tissue plasminogen activator (rt-
PA) induced reperfusion, and assessed tissue loss, functional outcomes, histopathology and 
changes in BBB permeability in young (3 mo.) and aged (18 mo.) Sprague-Dawley rats. Our 
data demonstrated that the BBB in aged animals is disrupted earlier and to a greater degree 
compared to young animals at 24 h post-MCAO and rt-PA treatment, and 20 min post-MCAO. 
Aged rats suffer strokes which are larger in size and have more severe functional 
consequences, providing a potential mechanism by which accelerated breakdown of the BBB 
during acute stroke leads to worsened outcomes. 
MATERIALS AND METHODS 
Animals 
This study was conducted in accordance with NIH guidelines for the care and use of animals in 
research. All protocols were approved by the West Virginia University Animal Care and Use 
Committee. Three groups of female, age-matched, Sprague-Dawley rats were investigated. 
Young (3-4 months; n=68), and aged (17-18 months; n=77) animals underwent an embolic 
middle cerebral artery occlusion (MCAO).  
Surgical Procedure for MCAO 
Rats were anesthetized with an intraperitoneal injection of 2.5 mg/kg flunixine, 90 mg/kg 
ketamine and 5 mg/kg xylazine, or with inhaled isoflurane (4% induction; 1% maintenance) for 
28 
 
BBB objectives. A servo-controlled homeothermic heating blanket, utilizing a rectal 
thermometer, was used to maintain body temperature at 37ºC. A cartridge based arterial blood 
gas machine (GEM Premier 3000, Instrumentation Laboratory, Lexington MA) was used to 
monitor arterial PaO2, PaCO2, pH and hematocrit. Blood from the femoral artery was analyzed just 
prior to embolization, during ischemia, and following recanalization. The femoral vein was 
catheterized for fluid replacement (1.4 ml/h 0.9% saline) and drug delivery. 
 Rats underwent selective embolization of the right middle cerebral artery (MCA), 
producing 120 min of ischemia, followed by rt-PA induced reperfusion utilizing a technique 
recently described (DiNapoli VA et al., 2006). Briefly, a microcatheter, outer diameter 0.3 mm, 
was inserted into the ICA via the ECA stump and advanced until its tip occluded the ipsilateral 
MCA. This mechanical occlusion was verified by laser Doppler (LD-CBF) monitoring of the MCA 
perfusion territory. The catheter was retracted until MCA flow was restored around the 
microcatheter. A 25 mm fibrin-rich, autologous blood clot was then injected directly into the 
MCA. Ischemia was monitored continuously for 120 min, rt-PA was administered via the femoral 
vein, and restoration of MCA flow was verified by LD-CBF.  
Functional Testing 
 Rats were handled and habituated to testing procedures in order to establish stable baselines 
on all measures. Animals were then tested repeatedly in a battery of functional assessments 
described below, beginning 24 h post-MCAO or sham operation and continuing daily for 1 week. 
Animals were then allowed to recover for an additional week and final assessments made at 




Composite Functional Score. The mNSS is a composite score of motor, sensory, 
balance and reflex measures and ranges from 1 to 17, with higher scores indicating greater 
neurological injury (Chen J et al., 2001; Germano et al., 1994; Seyfried et al., 2004). 
Bracing. Postural adjustments were assessed according to methods previously reported 
(Schallert et al., 1979). Animals were gently pushed laterally across a stainless steel bench top 
over a distance of 90 cm, at a rate of approximately 20 cm/s, by the experimenter's hand. Rats 
will generally adjust their posture, making numerous adjustments with their forelimb on the side 
to which they are being moved. These adjustments were tallied over two trials and analyzed. 
 Placing. This is a test of sensorimotor function previously reported to be effected by 
normal aging in rodents (Marshall, 1982). Animal were held suspended by the investigator, 
allowing free movement of the unsupported limbs. The animals were then brought to the edge of 
a bench top, such that its body was parallel to the table's edge its whiskers brushed against the 
top surface. The number of times the animal successfully raised its forelimb to the table top was 
tallied over a series of 10 trials for each forelimb. 
Tactile adhesive-removal test. Somatosensory function was tested as previously 
reported (Schallert et al., 1982; Schallert et al., 1983). A small adhesive paper circle ("Color 
Coding Labels", 1/4 inch in diameter, ACCO brands, Lincolnshire, IL) was placed on the distal-
radius area of each forelimb and placed back in cage. The time taken for the animals to remove 
to stimulus with its mouth was recorded over a series of three trials, with an inter-trial interval of 
1-2 min, and a maximum trial length of 180 s. The means from three trials were analyzed. 
Akinesia test. This test assesses the animal's ability to initiate movements with the 
paretic forelimb (Schallert et al., 1992). The rat was held by the experimenter such that one 
forelimb was allowed to rest on the table top and move freely. The number of steps taken with 
the limb over a 30 s trial was tallied for each forelimb. 
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TTC staining  
Animals were allowed to recover 24 h following MCAO and rt-PA reperfusion, anesthetized with 
Sleepaway (Fort Dodge Animal Health), and the brains were removed immediately and sliced 
coronally at 2 mm intervals. Slices were placed in 2%-2,3,5-triphenyltetrazolium chloride (VWR 
International, West Chester PA) in 0.1 M PBS for 20 min at 37ºC, scanned on a flatbed scanner 
and analyzed using Adobe Photoshop software (v7.0). Infarction volumes were determined 
according to the methods described by Yang et al (Yang ZW et al., 1998a). 
Tissue collection for frozen sections 
Animals were allowed to recover for designated period, anesthetized with Sleepaway (Fort 
Dodge Animal Health), and trancardially perfused with 100 ml of 0.09% saline followed by 
perfusion solution (4.0% w/v paraformaldehyde in 1X SPB). Brains were removed, placed in 
fixative for 24 h, cryoprotected in a series of 10, 20 and 30% sucrose w/v in DPBS solution for 
24 h per solution and sectioned at 35 µm. 
 Hematoxylin and eosin staining. Slide-mounted sections from three sham-controls and 
three randomly selected animals in each age group 24 h post-MCAO and rt-PA reperfusion, 
were rehydrated in DPBS for 5 min, and incubated in hematoxylin and eosin (Fischer Scientific) 
stain for 5 min at room temperature. Sections were rinsed for 5 min in running tap water and 
dehydrated for 5 min each in 75%, 95% and 100% ethanol, cleared in xylene, and coverslipped 
with Permount (Fischer Scientific). Sections were taken serially at 250 µm intervals, and 
examined utilizing light microscopy for areas of polymorphoneutrophil infiltration, hemorrhage 
and edema.  
 Fluoro-Jade B staining. Slide-mounted sections from three sham-controls and three 
randomly selected animals in each age group 24 h post-MCAO and rt-PA reperfusion were 
stained with Fuoro-Jade B. Slides were immersed in a solution of 1% sodium hydroxide in 80% 
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ethanol for 5 min, followed by immersion in 70% ethanol for 2 min, and distilled water for 2 min. 
The slides were transferred to 0.06% potassium permanganate for 10 min on a shaker to 
suppress background staining. Following a rinse in distilled water for 2 min, the slides were 
transferred to the staining solution for 20 min (stock FJB solution: 10 mg dye in 100ml distilled 
water; 0.004% working solution: 4 ml stock solution in 96 ml 0.1% acetic acid). The slides were 
washed three times for 1 min each in distilled water, and air-dried overnight. The slides were 
coverslipped directly with DPX (Fisher Scientific) 
Confocal Microscopy  
At 23 h following MCAO and rt-PA administration, 1 mg each of lysine fixable dextran (70,000 
Da; AlexaFlour 488) and fibrinogen (300,000 Da; AlexaFlour 568) dissolved in 0.5 ml of 0.9% 
saline were injected into the femoral vein. After 1 h, rats were anesthetized and transcardially 
perfused with 0.9% saline for 5 min then 4% paraformaldehyde/ 0.1 M sodium cacodylate buffer 
(pH 7.2). For 20 min assessments, fluorescent markers were injected 40 min prior to clot 
injection and animals were perfused, as stated above, 20 min post-MCAO.  Following perfusion, 
brains were removed and post fixed in 4% paraformaldehyde overnight. Areas around infarction 
were cut into 4 mm blocks, sliced into 60 μm sections, and assessed for fluorescent activity 
using a Zeiss LSM 510 confocal microscope and analyzed using Optimas analysis system.   
Evans blue albumin extravasation 
Albumin extravasation was quantified 24 h following MCAO and rt-PA reperfusion. Rats were 
anesthetized with 2.5mg/kg flunixine, 90 mg/kg ketamine and 5 mg/kg xylazine and the infused 
with 2% Evans blue (4 ml/kg) via the femoral artery. The Evan's blue was allowed to circulate for 
1 h and the rats were perfused with cold phosphate buffered saline (pH 7.4) for 15 min via the 
left ventricle.  The brains were excised; meninges and ependymal organs removed, 
hemispheres excised, separated, weighed, and homogenized in 500 µl of 50% trichloroacetic 
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acid.  The tissue was incubated for 24 h at 37ºC, and then centrifuged at 13,000 X g for 10 min.  
The supernatants were diluted four-fold with absolute ethanol; fluorescence intensity was 
measured using a fluorometer at 620 nm excitation, 680 nm emission (Beckman DU 640). 
Calculations were based on external standard readings and extravasated dye was expressed as 
ng EB/mg brain tissue.  
Statistical Analysis 
Data and figures are presented as means ± SE. Physiologic parameters and functional data 
were compared by two-way ANOVA with groups of age (young and aged) by treatment (pre- or 
post-stroke), followed by Tukey’s post-hoc evaluation. Infarction volumes and EB data were 
compared by one-way ANOVA. Post-hoc t-tests were performed as directed by ANOVA 
outcomes. P<0.05 was considered statistically significant. 
RESULTS 
Physiologic Variables 
Physiologic data for groups subjected to MCAO are presented in Table 2.1. Significant 
differences between groups were not observed, and values are within normal physiologic 
ranges. 
Mortality 
Aged animals exhibited a 33% mortality rate at 24 h post-MCAO and rt-PA reperfusion with 12 
of 36 animals dying during the first day of recovery, young animals suffered 17% mortality (5 of 
29). In the group receiving MCAO only, 4 of 9 aged animals and 2 of 7 young animals died 
during the 24 h recovery period. There were no deaths amongst sham-operated animals or prior 
to 20 min sacrifice. The final analyses included 42 sham-operated controls, 65 rats with 120 min 
MCAO and rt-PA reperfusion, 16 rats with 120 min MCAO and 22 rats with 20 min MCAO.  
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Tissue loss is exacerbated in aged animals 
Infarction volumes were significantly affected by animal age in both the cortical (F[2,27]=8.5, 
P=0.001) and striatal (F[2,27]=6.9, P=0.004) regions, 24 h following 120 min MCAO and rt-PA 
induced reperfusion (Figure 2.1, C). The percentage of infarcted cortex relative to contralateral 
hemisphere was significantly higher in the aged (Figure 2.1, B) group (63±9%) when compared 
to the young (Figure 2.1, A) (26±6%, P=0.002). Striatal infarction volumes were also significantly 
greater in the aged group (53±5%) relative to the young (33±4%, P=0.006).    
Increased hemorrhage and infiltration of inflammatory cells into the infarct is observed in 
aged animals 
At 24 h following MCAO and rt-PA reperfusion, brains from three animals in both age groups 
were harvested for pathological examination. Figure 2.2 displays representative 
photomicrographs (H&E) of slices from a young and aged rat. In the young animal (Figure 2.2, 
A), a central area of coagulation necrosis is evident. This area contains sparse aggregates of 
acute inflammatory cells (PMNs). Penumbra contains swollen neurons, some with vacuolated 
neuropil. In the aged animal (Figure 2.2, B), the area of coagulation necrosis is partially 
obscured by dense inflammatory cell infiltration and petechial hemorrhages. Increased 
vacuolation of the neuropil is evident.  
Functional deficits are more severe with prolonged recovery in aged animals  
All animals were assessed for gross neurologic competence after awakening from anesthesia. 
Behavioral deficits were grossly apparent in both age groups throughout the 14 d testing period, 
with the persistence of circling in 4 of 10 young animals and all aged animals. Impairment in 
normal feeding and grooming behavior was observed by 1 day post-MCAO. A red Harderian 
gland secretion surrounding the eyes and nostrils was present in most animals during the initial 
48-72 h period, indicating significant stress following the insult. Feeding and grooming behavior 
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returned in all young animals by 7 d following MCAO, however, 4 of the 10 aged animals 
remained severely impaired until time of sacrifice.  
 Consistent with gross observations, behavioral assays detected significant functional 
impairment compared to baseline in both the young and aged animals throughout the recovery 
period (Figure 2.3). Animals were tested for neurological competence utilizing the modified 
neurologic severity scale (mNSS) (Chen J et al., 2001), sham-operated animals are represented 
as day 0. ANOVA demonstrated a significant effect of age on functional severity of stroke 
(F[2,27]=17.07, P<0.001) (Figure 2.3, A), with elevated mNSS scores correlating to increased 
severity of functional impairment.  
 Results of the bracing test showed a significant effect of treatment on performance of 
both young and aged rats throughout the 14 d testing period (F[8,72]=5.83, P<0.001) (Figure 
2.3, B). Additionally, age had a significant affect on performance (F[1,72]=223.06, P<0.001). 
Sham-controls in the aged group (10.4±0.6) demonstrated decreased baseline performance 
when compared to young sham-controls (13.6±0.24) (P<0.01).  
 Results of the placing test showed a significant effect of treatment on performance of 
both young and aged rats throughout the 14 d testing period (F[8,72]=24.69, P<0.001) (Figure 
2.3, C). Additionally, age had a significant affect on performance (F[1,72]=933.11, P<0.001). 
Young animals fully recovered in this task by day 14, with a peak deficit of 8.6±0.74 
responses/10 trials. Aged animals recovered to a mean of 4.4 responses/10 trails by day 14, 
with a peak deficit of 0 responses on days 1-3.  
 Results of the tactile removal test showed a significant effect of treatment on 
performance of both young and aged rats throughout the 14 d testing period (F[8,72]=22.64, 
P<0.001) (Figure 2.3, D). Additionally, age had a significant affect on performance 
(F[1,72]=13.2, P<0.001). Young animals showed significant recovery in this task by day 7 with a 
35 
 
mean removal time of 96.3±29.6 s, and a peak deficit of 170.6±9.3 s on day 1. Aged animals did 
not show meaningful recovery. 
  Results of the akinesia test showed a significant effect of treatment on performance of 
both young and aged rats throughout the 14 d testing period (F[8,72]=21.5, P<0.001) (Figure 
2.3, E). Additionally, age had a significant affect on performance (F[1,72]=98.8, P<0.001). 
Young animals showed moderate recovery in this task by day 14 with a mean of 26±2.7 steps, a 
baseline of 43.6±0.9 and a peak deficit of 16.4±3.3 steps on day 1. Aged animals did not show 
meaningful recovery with a mean of 10.6±1.3 steps on day 14, a baseline of 40.4±1.9 and a 
peak deficit of 7±1.6 steps on day 1.  
BBB permeability 24h post-MCAO is two-fold greater in the aged brain 
BBB permeability in young and aged rats was assessed at 24 h post-MCAO by quantifying 
extravasation of albumin (Figure 2.4, A) and visualization of fluorescent vascular markers by 
confocal microscopy (Figure 2.4, B frames 3-6). Administration of rt-PA (5 mg/kg) at 2 h after 
MCAO significantly (p<0.01) reduced albumin extravasation in infarcted hemispheres of both 
young and aged rats at 24 h post-MCAO (Figure 2.4, A). Aged animals demonstrated a 212% 
increase in BBB permeability to albumin in the infarcted hemisphere as compared to young 
animals at 24 h post-MCAO and rt-PA reperfusion (Figure 2.4, A; p<0.01). No significant 
(p>0.05) difference in albumin extravasation at the BBB was noted between contralateral 
hemispheres of young and aged rats (Figure 2.4, A) nor in comparing contralateral hemispheres 
of young and aged rats to age-matched sham control hemispheres (data not shown).  
 Figure 2.4 B (frames 3-6) depict a visualization of cerebral microvessels in an area 
adjacent to the infarct (penumbra) of young (frame 3) and aged (frames 4-6) rats at 24 h post-
MCAO and rt-PA reperfusion using two vascular space markers (dextran-70 kDa  and 
fibrinogen-300 kDa). Frame 3 shows fibrinogen outlining the circuitous pattern of microvessels 
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with no apparent detection of dextran in the microvessels or extracellular space. Frame 4 shows 
fibrinogen outlining microvessels and the appearance of punctate regions of dextran in the 
extracellular space. Frame 6 is a brightfield image that clearly shows fibrinogen 
immunofluorescence is confined to the luminal side of the microvasculature and dextran is 
found only in the extracellular fluid. Frame 5 is an image of the contralateral side of an aged rat 
24 h post-MCAO and rt-PA reperfusion.     
Functional disturbance of the BBB by 20 min post-MCAO 
BBB permeability in young and aged rats was assessed at 20min post-MCAO by quantifying 
extravasation of albumin (Figure 2.5, A) and visualization of fluorescent vascular markers by 
confocal microscopy (Figure 2.5, B frames 3 and 4). Aged animals demonstrated a 175% 
increase in BBB permeability to albumin in the infarcted hemisphere as compared to young 
animals at 20 min post-MCAO (Figure 2.5, A; p<0.001). No significant (p>0.05) difference in 
albumin extravasation at the BBB was noted between contralateral hemispheres of young and 
aged rats (Figure 2.5, A) or in comparing contralateral hemispheres of young and aged rats to 
age-matched sham control hemispheres (data not shown).  
 Figure 2.5 B (frames 3 and 4) depict a visualization of cerebral microvessels in an area 
adjacent to the infarct of young (Frame 3) and aged (Frames 4) rats at 20 min post-MCAO using 
two vascular space markers (dextran-70 kDa  and fibrinogen-300 kDa). Frame 3 shows 
fibrinogen outlining the microvessels with no apparent detection of dextran in the microvessels 
or extracellular space. Frame 4 shows fibrinogen outlining microvessels and the appearance of 
dextran in the surrounding extracellular space.  No difference in dextran extravasation was 
noted between contralateral hemispheres of young and aged rats or in comparing contralateral 




Neuronal damage is preceded by BBB disruption 
Neuronal damage in young and aged rats was assessed at 24 h post-MCAO and rt-PA 
reperfusion (Figure 2.4, B frames 1 and 2) and 20 min post-MCAO (Figure 2.5B frames 1 and 2) 
by Fluoro-Jade B staining. Aged (Figure 2.4, B frame 1)  animals demonstrated increased 
severity of injury, characterized by increased density and intensity of staining, as well as a 
greater degree of vacuolation compared to young (Figure 2.4,B frame 1)  rats. The transition 
from severe neuronal injury within the MCA distribution to survival within the penumbra can be 
observed. 
 No difference in intensity of staining was seen between aged (Figure 2.5, B frame 1) and 
young (Figure 2.4, B frame 2) animals at 20 min post-MCAO. Early neuronal damage could not 
be revealed utilizing the Fluoro-Jade B staining technique in the young or aged animals. 
DISCUSSION 
We demonstrated that aged rats suffered more severe infarcts with increased disruption of the 
BBB, a greater degree of neuronal damage, and reduced functional recovery following MCAO. 
In addition, we found that rt-PA (5 mg/kg) induced reperfusion at 120 min post-MCAO produced 
a significant decrease in disruption of the BBB to albumin in young and aged animals at 24 h 
following MCAO. Finally, we report data that suggests BBB disruption occurs prior to observable 
neuronal damage during MCAO; thus, suggesting a potential mechanism by which alterations in 
BBB functional integrity during stroke contribute to the degree of subsequent neuronal damage. 
 A primary concern of this study was the use of rt-PA in rodents. Prior investigations have 
administered an rt-PA dosage 10-20 times the therapeutic dose for humans. A primary reason 
for this discrepancy in dose was that rt-PA is produced by human recombinant DNA, and 
species variations decrease rt-PA efficacy in rodents. In humans, rt-PA is administered at a 
dosage of 0.9 mg/kg and has a narrow therapeutic window. Since introduction in 1995, rt-PA 
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has remained the only approved method of drug induced thrombolysis for acute ischemic stroke 
(1995). These breakthroughs have been hindered by unwanted consequences of rt-PA 
treatment, most prominently the increased risk of hemorrhagic transformation and neurotoxicity 
(1995;Jiang et al., 2003). 
 Successful and reproducible thrombolysis was achieved in rodents at half the rt-PA dose 
which is commonly administered, limiting the deleterious effects. The drug was only 
administered according to NIH suggested guidelines, and both young and aged rats were 
routinely screened for intracranial hemorrhage following administration (DiNapoli VA et al., 
2006). Young and aged rats underwent 120 min of stable MCA occlusion, followed by 
administration of rt-PA for recanalization. Duration of occlusion and successful reperfusion of 
the MCA territory was verified by laser Doppler; furthermore, the reperfusion profile was similar 
to that seen in a clinical setting.  Previous studies have reported mortality rates (up to 80%) 
amongst aged animals receiving 60-120 minutes of filamentous occlusion, which would 
preclude further use in MCAO models (Futrell et al., 1991;Hachinski et al., 1992;Wang et al., 
1995;Wang et al., 2003a). This model produced a 33% mortality rate in the aged animals. 
Administration of rt-PA at 120 min post-occlusion resulted in significantly decreased disruption 
of the BBB and reduced mortality in both young and aged animals.   
 Studies have produced varied results concerning the effect of age on stroke outcome. In 
comparison to young rats, the aged rats in this study showed nearly a two-fold increase in 
infarction volume. The principal difference in infarction size can be attributed to larger 
involvement of the cortical brain region in aged animals. The current study produced larger 
infarctions volumes in all age groups and brain regions, compared to suture occlusion (Rosen 
CL et al., 2005). In addition, histopathology of the infarcted region in aged animals distinctly 
revealed advanced vacuolation of the neuropil, increased infiltration of polymorphoneutrophils 
and pettichial hemorrhaging not seen in younger animals. These findings demonstrate that 
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cerebral ischemia in aged rodents creates infarcts which are structurally different than those 
generated by equivalent insults in younger animals. 
 The intact BBB has negligible transport of albumin into the brain; however, susceptibility 
of the BBB has been documented in a number of diseases. Evidence has suggested that a 
damaged endothelial barrier results in BBB disruption contributing to the progression and onset 
of several neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases (Ariga 
et al., 1998; Mackic et al., 2002). Under homeostatic conditions, the BBB remains functionally 
intact during aging (Mooradian AD, 1988); however, becomes more susceptible to disruption by 
external factors with increasing age (Daniel et al., 1978; Burns EM et al., 1981; Shah and 
Mooradian, 1997).  
 In this study, we measured Evan's blue albumin extravasation into the brain parenchyma 
of infarcted and non-infarcted hemispheres in young and aged rats at 20 min and 24h post-
MCAO, and 24 h post-MCAO with rt-PA induced reperfusion. Young and aged rats exhibited a 
significant increase in BBB permeability to albumin 24 h post-MCAO and rt-PA reperfusion, and 
this disruption was two-fold greater in the aged compared to the young rats. Confocal 
microscopy confirmed leakage of albumin sized molecules across the BBB in aged animals. 
Microscopy demonstrated extravasation of dextran (70 kDa) in an area adjacent to, but not 
within, the infarct of aged animals. The failure to observe dextran in the penumbral region of the 
infarct in young rats suggests that the BBB is still functionally intact. Fluoro-Jade B staining 
assessed the degree of neuronal injury present, and demonstrated grossly observable damage 
within the MCA fed territory of young and aged animals. In addition, the aged rats exhibited 
increased intensity of staining within injured neurons, as well as vacuolation of the neuropil in 
agreement with histopathology.   
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 A significant increase in albumin extravasation was also noted at 20 min post-MCAO in 
both age groups. The disruption in aged animals was again nearly 2-fold that seen in the young 
group and was greater than 3-fold that observed in the contralateral hemisphere. Confocal 
microscopy demonstrated the presence of dextran (70 kDa) in the extracellular space 
surrounding the MCA perfusion territory at 20 min post-MCAO in aged rats, while Fluoro-Jade B 
staining did not reveal neuronal injury at this time point. These data demonstrate a functional 
alteration in the barrier's ability to maintain a separation between systemic circulation and the 
brain parenchyma, ultimately contributing to cytotoxic changes in the extracellular environment. 
The presence of this disruption preceding observable neuronal injury suggests that exacerbated 
breakdown of the BBB in aged rats during acute stroke may contribute to the worsened 
outcomes observed. Furthermore, it may be important to consider the stabilization of the barrier 
in investigating new therapeutic interventions for stroke. 
 Evaluation of functional impairment has become a prominent focus in development of 
preclinical models, as results gained can be correlated to subsequent clinical assessment in 
stroke victims. Inclusion of aged animals in long-term functional assays has proven problematic 
due to impractically high mortality rates. Previous reports have addressed this issue by creating 
an incomplete filamentous occlusion, limiting the amount of tissue loss and lowering long term 
mortality  in the aged animals to approximately 24% (Lindner et al., 2003). Their experiments 
produced long-lasting functional deficits amongst the aged rats, and allowed for functional 
evaluation in the aged group (age 16 months) out to 90 days post-occlusion. This approach 
certainly provides a compliment to the traditional use of young animals, which show less initial 
deficit and recover more quickly; however, the previously mentioned shortcomings of 
filamentous occlusion remain, as well as the inability to study rt-PA reperfusion and infarctions 
representative of larger strokes. 
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 In utilizing functional assessments previously reported (Lindner et al., 2003), the current 
study examined functional deficits in young and aged animals following 120 min embolic MCAO 
and rt-PA induced reperfusion. Functional deficits seen in young animals were very similar to 
previous reports, showing a moderate initial deficit followed by significant recovery over a two 
week period. Aged animals in this study, however, showed severe initial deficits, with a dense 
and profound paresis of the limbs on the affected side and significantly poorer performance on a 
battery of functional challenges. Additionally, aged animals never exhibited functional 
competence equivalent to the young animals at any time point and recovery was prolonged. 
Thus aged rats had a functional status very similar to that seen clinically in patients having 
suffered a stroke. 
 The need for an accurate preclinical MCAO model that mimics the stroke population and 
allows for effective, reliable reperfusion is imperative for the successful translation of therapeutic 
strategies and improved stroke outcomes. Hope for potential neuroprotective agents has 
spurred intense research interest in basic science investigation and clinical trials, yet no 
effective agent has been found. This study clearly demonstrated that age has a profound 
influence on acute brain damage and subsequent functional recovery following an MCAO and 
rt-PA reperfusion. These data further the consensus that stroke models should be developed in 
older animals, and that use of aged animals in preclinical models may increase their clinical 
relevance and predictive validity (Millikan, 1992). To our knowledge, this is the first study to 
report reproducible reductions in MCA flow using an embolic technique, with consistent rt-PA 
induced reperfusion and acceptable mortality rates in aged animals. Additionally, we begin to 
explore the role of the aging BBB and how alterations to this structure during acute stroke affect 
outcome. Early disruption of the BBB in aged animals during stroke provides a mechanism by 
which this breakdown contributes to subsequent neuronal damage, and is a critical element to 
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consider in the development and implementation of effective therapeutic strategies for treatment 







Figure 2.1.  TTC stained sections representative of young (A) and age (B) infarction distribution 
24 h post-MCAO and rt-PA reperfusion. C, Volumetric analysis of cerebral infarctions.  Infarction 
volumes are expressed as a percentage of the contralateral structure ± SE. * Significant 






Figure 2.2.  Representative photomicrographs of slices from young (A) and aged (B) animals, 
24 h post-MCAO and rt-PA treatment. In the young rats (A), a central area of coagulation 
necrosis is evident (closed arrowhead). This area contains sparse aggregates of acute 
inflammatory cells (*) (PMNs). The margin of the infarct contains swollen neurons, some with 
vacuolated neuropil (arrow). In the aged animals (B), the area of coagulation necrosis (closed 
arrowhead) is partially obscured by dense inflammatory cell infiltration (*) and petechial 








Figure 2.3.  Performance on functional tests performed from 1-14 d post-occlusion to access 
neurological deficit. A, mNSS, A composite functional score, judged on a scale of 0 to 17 with 
higher scores correlating to increased severity of functional deficits (N=10/group). B, Bracing 
test reflects number of postural adjustments made by the animals while being pushed laterally 
toward the paretic side over 90 cm (N=5/group). C, Placing test reflects the number of directed 
paw placements made in response to somatomotor stimulus over 10 trials (N=5/group). D, 
Tactile removal test reflects the time taken for animal to remove somatosensory stimulus placed 
on distal forearm (N=5/group). E, Akinesia test reflects the number of steps made with usable 







Figure 2.4.  A, Extravasation of albumin across the BBB assessed by quantification of Evan's 
blue dye 24 h post-MCAO. Aged group untreated and treated with rt-PA exhibited greater BBB 
permeability in relation to corresponding young animals and contralateral hemisphere (*, 
P<0.01) (N=5). B, Photomicrographs of Fluoro-Jade B stained sections from a young (frame 1) 
and aged (frame 2) animals 24 h post-MCAO and rt-PA reperfusion. Damaged neurons within 
the infarcted region are fluorescently stained (green), while surviving neurons within the 
pneumbra are left unstained (Scale bar = 100 μm). Frames 3-6, Confocal microscopy of 
vascular permeability markers dextran (70 kDa) and fibrinogen (300 kDa) 24 h post-MCAO and 
rt-PA reperfusion, taken in the penumbral region of the infarct. Frames 3 and 4, Confocal 
images of fibrinogen (red) and dextran (green) reactivity in the ipsilateral cortex of young (frame 
3) and aged (frame 4) animals. No dextran extravasation is observed in the young animal 
(frame 3) and is similar to images from contralateral hemisphere of the aged animal (frame 5). 
Dextran is present in the extracellular space of aged (frame 4) animals at the same time point. 
Panel 6, Image in bright field that depicts lumen of cerebral microvessel. Fibrinogen can be 
seen remaining within the lumen of the vessel, while dextran reactivity is present along the outer 










Figure 2.5.  A, Extravasation of albumin across the BBB assessed by quantification of Evan's 
blue dye 20 min post-MCAO. Aged group exhibited greater BBB permeability in relation to 
corresponding young animals and the contralateral hemisphere (*) (P<0.001). B, 
Photomicrographs of Fluoro-Jade B stained section from a young (frame 1) and aged (frame 2) 
animal 20 min post-MCAO. Damaged neurons were not observed within the MCA perfusion 
territory in either young or aged animals (Scale bar = 100 μm). Frames 3 and 4, Confocal 
images of fibrinogen (red) and dextran (green) reactivity in the ipsilateral cortex of young (frame 
3) and aged (frame 4) animals, taken in the penumbral region of the infarct. No dextran 
extravasation is appreciated in the young rats (3) and is similar to images from contralateral 
hemisphere of the aged rats (not shown). Dextran is present in the extracellular space of aged 






Supplemental Figure 2.1.  All animals experienced an equivalent reduction and restoration of 
cerebral blood flow. Laser Doppler cerebral blood flow (LD-CBF) was monitored throughout the 
experiment. Chart represents mean percentage of baseline LD-CBF values±SE, at equivalent 
time points, throughout the experiment. There are no significant differences between the means 
at any time point. The 3 month old group demonstrated a higher LD-CBF with initial reperfusion 






Table 2.1. Summary of Physiological Values Pre-, During and Post-Middle  





% Hct MAP (mm Hg) (mm Hg) 
    
Young      
Pre (10) 7.44±0.07 32±8.1 109±6.8 36±3.2 80±7.8 
During (10)     89±11.5 
Post (10) 7.39±0.05 37±4.9 97±5.3 35±3.3 102±18.1 
      
Aged      
Pre (10) 7.43±0.07 34±6.8 114±7.3 34±2.5 84±13.7 
During (10)     79±13.0 













NOX2 inhibition with apocynin worsens stroke outcome in aged rats. 
 





Background and Purpose:  This study utilized middle cerebral artery occlusion (MCAO) with 
tissue plasminogen activator (tPA) to assess inhibition of the NOX2 isoform of NADPH oxidase 
on brain injury and functional recovery in aged rats.  
Methods:  Effects of NOX2 on the degree of brain injury and functional recovery following 
MCAO and tPA reperfusion was assessed in young adult and aged rats. Rats received apocynin 
(NOX2 inhibitor; 5 mg/kg) or saline 30 min prior to MCAO.  At 24 h following MCAO, blood-brain 
barrier permeability (BBB), stroke infarct volume, edema formation, and oxidative damage were 
measured. 
Results:  Apocynin treatment in aged rats increased mortality rate and failed to improve 
functional outcome, total infarct volume, edema formation, and BBB permeability.  Aged rats 
displayed increased BBB permeability to sucrose in the contralateral hemisphere following 
MCAO and diminished antioxidant capacity in the brain as compared to young adult rats.   
Conclusions:  We conclude that inhibition of NOX2 in the aged rat exacerbates stroke injury and 
diminishes functional outcome. These results suggest age is an important factor in stroke 
damage and more rigorous examination of apocynin as a therapeutic agent for treatment of 





NADPH oxidases are a damaging source of reactive oxygen species during the aging process 
(Park L et al., 2007; Hamilton CA et al., 2001).  Inhibition of the NOX2 isoform of NADPH 
oxidase reduces superoxide formation (Tang et al., 2007), prevents oxidative damage in the 
vasculature (Godbole et al., 2009; Park et al., 2008), and was recently touted as a promising 
therapeutic target for treatment of stroke (Kahles T et al., 2007).  Studies using embolic models 
of stroke have identified many neuroprotective agents; however, none of these drugs have 
improved stroke outcome in humans (Gladstone DJ et al., 2002).  Most preclinical studies have 
been conducted in young rodents.  We contend that aging impacts brain damage and functional 
recovery following stroke and that by not focusing on age-related processes, a vast area of 
potential therapeutic growth has been overlooked.  This study utilized middle cerebral artery 
occlusion (MCAO) with tissue plasminogen activator (tPA) reperfusion to assess inhibition of 
NOX2 on brain injury and functional recovery in aged rats.  Our results demonstrated that age is 
an important factor in stroke damage and suggest more rigorous examination of NOX2  
inhibition as a therapeutic strategy for treatment of acute ischemic stroke is needed.   
EXPERIMENTAL PROCEDURE 
MCAO and Apocynin Treatment 
Female rats were used in this investigation due to the exaggerated sexual dimorphism of size 
and weight in young adult versus aged males.   Female Sprague-Dawley rats [(3-4 months, 260-
280 g, n=92) and (18-20 months, 275-350 g, n=120)] were received from Harlan (Indianapolis, 
IN) and housed under natural light/dark conditions with food and water available ad libitum.  
Procedures involving animals abided by the West Virginia University Animal Care and Use 
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Committee.  Before MCAO or sham surgery, rats from both age groups were randomly divided 
into apocynin (5 mg/kg; i.p.) and vehicle (0.9% saline; i.p.) treated groups.  Treatment was 
administered 30 min prior to surgery. Rats were anesthetized with ketamine (90 mg/kg; i.p.; 
Webster Veterinary; Sterling, MA) and xylazine (5 mg/kg; Webster Veterinary) prior to surgery 
and then supplemented as needed. Rats underwent MCAO for 2 h followed by tPA (Genentech; 
San Francisco, CA)-induced reperfusion as previously described (DiNapoli VA et al., 2006).  
Briefly, a micro-catheter was inserted into the internal carotid artery (ICA) and advanced until its 
tip occluded the ipsilateral MCA.  This mechanical occlusion was verified by laser Doppler (LD-
CBF) monitoring of the cerebral blood flow in the MCA perfusion territory.  A 25 mm fibrin-rich, 
autologous blood clot was then injected directly into the MCA.  Sham surgery consisted of all 
steps above except for occlusion of the MCA.  Ischemia was monitored continuously.  At 2 h, 
tPA (5 mg/kg) was administered via the femoral vein, and restoration of blood flow through the 
MCA was verified by LD-CBF.  Ischemia was defined as a perfusion drop across the MCA 
territory of >80% as determined by laser Doppler and successful reperfusion was denoted as a 
return to >80% of baseline perfusion rate by 30 min after tPA administration.  At a dose of 5 
mg/kg i.v., tPA decreases BBB permeability in both young adult and aged rats 24 h after 
embolic MCAO (DiNapoli VA et al., 2008).  Furthermore, a recent study from our lab utilizing 
EEIIMD (a hexapeptide that binds non-thrombolytic sites on tPA) provides evidence that while 
some cortical damage could be due to non-thrombolytic actions of tPA; largely, striatal and total 
stroke volume are not exacerbated by tPA (Tan et al., 2009).   
Functional Testing 
At 24 h following MCAO, functional testing was performed using the modified Neurological 
Severity Scores (mNSS), which is a composite score of motor, sensory, balance and reflex 




Determination of Infarct Volume and Edema Formation  
At 24 h following MCAO, rats (n=6) were anesthetized with ketamine and xylazine, sacrificed by 
decapitation, brains removed and sliced coronally at 2 mm intervals. Sections were incubated in 
2% 2,3,5-triphenyltetrazolium chloride (TTC) for 20 min at 37ºC.  Following TTC staining, infarct 
volumes were quantified according to method previously described (Yang ZW et al., 1998a).  
For each brain section, ischemic area was outlined and infarct volume calculated.  To avoid 
overestimation of infarct volume, the corrected infarction volume (CIV) was calculated: CIV=(LA-
[RA-RI])xd, where LA was area of the left hemisphere (mm2), RA was area of the right 
hemisphere (mm2), RI was the infracted area (mm2), and d was slice thickness (2 mm).  Edema 
index (%) was calculated according to previously described method (Maier et al., 1998).  Briefly, 
edema index=(RV-LV)/LVx100%, where RV was volume of right hemisphere (mm3) and LV was 
volume of left hemisphere (mm3). 
Blood-brain barrier (BBB) permeability 
At 24 h following MCAO, In situ brain perfusion and capillary depletion were carried out as 
described previously (n=6) (Preston JE et al., 1995; Triguero D et al., 1990).  Briefly, rats were 
anesthetized with ketamine (90 mg/kg; i.p.) and xylazine (5 mg/kg; i.p.) and heparinized (10,000 
U/kg; i.p.).  The common carotid arteries were exposed, cannulated and perfused with modified 
Krebs-Henseleit Ringer’s (117 mmol/L NaCl; 4.7 mmol/L KCl; 0.8 mmol/L MgSO4; 24.8 mmol/L 
NaHCO3; 1.2 mmol/L KH2PO4; 2.5 mmol/L CaCl2; 10mmol/L D-glucose; dextran (70,000 Da) 29 
g/L; bovine serum albumin 10 g/L), aerated with 95% O2/5% CO2 and warmed to 37°C.  With 
start of the perfusion jugular vein was sectioned to allow for drainage.  Once both arteries were 
cannulated, [14C]-sucrose was infused (flow rate: 0.5 ml/min) into the inflowing Ringer’s solution 
(total flow rate: 3.6 ml/min/hemisphere).  After 20 min, the brain was flushed for 20 s with 
unlabeled Ringer’s solution and the rat sacrificed by decapitation.  The brain was removed, 
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dissected into ipsilateral and contralateral hemispheres and the choroid plexis and meninges 
excised.  Brain tissue samples (~150 mg wet weight) and 100 μl of perfusate samples were 
prepared for radioactive counting by addition of 1 ml of tissue solubilizer (TS-2; Research 
Products Inc.; Mount Prospect, IL).  After 72 h in TS-2, 250 μl glacial acetic acid and 4 ml 
scintillation cocktail (Bio-Safe NA; Research Products Inc.) were added and samples analyzed 
by liquid scintillation counting (Beckman LS5801; Beckman Coulter; Fullerton, CA).  Amount of 
[14C] radioactivity in the brain (Ctissue; dpm/g) was expressed as a percentage of that in artificial 
perfusate (Cperfusate; dpm/ml) and termed Rtissue% (µl/g) as follows: Rtissue% = (Ctissue / Cperfusate) x 
100%.   
Capillary depletion was carried out after in situ perfusion, the brain was removed dissected into 
ipsilateral and contralateral hemispheres and choroid plexis and meninges excised.  
Hemispheres were homogenized in 1.5 ml capillary depletion buffer (4-[2-hydroxyethyl]-1-
piperazineethanesulfonic acid (HEPES); 141 mM NaCl; 4 mM KCl; 2.8 mM CaCl2; 1 mM 
MgSO4; 1 mM NaH2PO4; 10 mM D-glucose; pH 7.4) maintained at 4ºC.  An equal volume of ice-
cold 26% dextran (60,000 Da) solution was added to homogenate.  Aliquots of homogenate 
were taken and centrifuged at 5,400 x g for 15 min.  Capillary depleted supernatant was 
separated from the vascular pellet.  Homogenate, supernatant, and resuspended vascular pellet 
were assayed for radioactivity using a liquid scintillation counter. 
Markers of oxidative stress 
At 24 h following MCAO, rats (n=6) were anesthetized with ketamine and xylazine and 
transcardially perfused with 0.9% saline with heparin (2 U/ml).  Brains were removed, and the 
ipsilateral and contralateral hemispheres separated. Brain sections were weighed and stored at  
-80°C.  Measurement of superoxide dismutase (SOD), glutathione peroxidase (GPx), and 
catalase (CAT) activities as well as, thiobarbituric acid reactive substances (TBARS) in the form 
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of malondialdehyde (MDA) and protein carbonyl were carried out according to manufacturer’s 
protocols(Cayman Chemicals; Ann Arbor, MI). 
Statistics 
Data are presented as mean ± S.E.  BBB permeability and oxidative stress assays were 
compared by three-way (ANOVA) with Tukey’s post hoc analysis.  Functional score, stroke 
infarct volume and edema formation were compared by two-way ANOVA with Tukey’s post hoc 
analysis.  Statistical significance was set at p<0.05.    
RESULTS 
A total of 92 young adult and 120 aged rats were used in this study.  At 24 h following MCAO, 
apocynin treatment led to increased mortality in aged rats from 14% (7 of 51) to 36% (25 of 69).  
Vehicle-treated aged rats suffered higher mortality than young adult rats (6%; 3 of 45).  In young 
adult rats, treatment with apocynin (10%; 5 of 47) had no effect on mortality.  No rats were 
excluded from the study for not meeting the criteria for ischemic depth and reperfusion.  No 
deleterious signs of hemorrhage from tPA use were observed in the study.  These findings were 
consistent with prior studies showing that administration of tPA at 5 mg/kg at 2 h after start of 
vessel occlusion did not worsen and, in fact, improved infarct volume compared to ischemic 
injury following suture occlusion and reperfusion (DiNapoli VA et al., 2006; DiNapoli VA et al., 
2008;Tan et al., 2009).    
Functional Score  
At 24 h following MCAO, neurological function was assessed using a modified mNSS (Figure 
3.1).  Aged rats (11±1) suffered worsened functional outcome compared to young adult rats 
(8±0.5).  While apocynin improved functional outcome in young adult rats (5±1), no 




At 24 h following MCAO, cortical, striatal and total stroke infarct volumes were calculated from 
TTC stained brain sections (Figure 3.2 A-C).  Apocynin-treated aged rats displayed no 
improvement compared to vehicle-treated aged rats in cortical (27±4% and 21±4%, 
respectively), striatal (62±7% and 80±5%, respectively) or total (33±3% and 31±3%, 
respectively) stroke volumes.  Aged rats exhibited significantly worsened cortical (21±4% and 
10±2%, respectively) and total (31±1% and 19±2%, respectively) stroke volumes compared to 
young adult rats.  Treatment with apocynin significantly decreased striatal (33±10% and 72±7%, 
respectively) and total (6±2% and 19±2%, respectively) stroke volume in young adult rats 
compared to vehicle-treated young adult rats. 
Edema Formation 
At 24 h following MCAO, edema formation was measured (Figure 3.2D).  Apocynin treated aged 
rats (20±2%) had exacerbated edema as compared to vehicle-treated aged rats (6±3%).  No 
difference in edema formation between young adult, young adult apocynin treated, and aged 
rats was observed.    
BBB Permeability 
At 24 h following MCAO, BBB permeability was measured utilizing a 20 min in situ brain 
perfusion with [14C]sucrose (Figure 3.3).  Aged rats treated with apocynin showed no difference 
in BBB permeability compared to vehicle-treated aged rats. The ipsilateral hemisphere of aged 
rats (4.2±0.2%) showed increased permeability of [14C]sucrose compared to both young adult 
MCAO rats (2.9±0.4%) and aged sham rats (2.0±0.1%).  Following MCAO, aged rats also 
demonstrated increased permeability to [14C]sucrose in the contralateral hemisphere (2.9±0.2%) 
as compared to aged sham rats (2.0±0.1%).  The ipsilateral hemisphere of young rats 
(2.9±0.4%) exhibited increased permeability of [14C]sucrose as compared to young adult sham 
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rats (1.6±0.1%).  When treated with apocynin 30 min prior to MCAO, young adult rats exhibited 
attenuated BBB permeability (2.0±0.2%).   
Enzyme activity 
At 24 h following MCAO, aged rats treated with apocynin showed reduced SOD activity 
compared to respective young adult rats (Figure 3.4).  Following MCAO, young adult rats had 
reduced GPx in the contralateral hemisphere (321±66 nmol/min/ml) compared to young adult 
sham rats (471±36 nmol/min/ml).  Treatment with apocynin in young adult rats reduced GPx in 
the ipsilateral hemisphere (205±55 nmol/min/ml and 605±57 nmol/min/ml respectively), and 
GPx (138±35 nmol/min/ml and 321±68, respectively) and CAT (71±0.6 mmol/min/ml and 
115±15 mmol/min/ml, respectively) in the contralateral hemisphere compared to vehicle-treated 
young adult rats.  When compared to young adult sham rats, aged sham rats had decreased 
SOD (805±80 U/ml and 388±82 U/ml respectively) and GPx (471±36 nmol/min/ml and 348±66 
nmol/min/ml respectively).   
Oxidative Damage 
At 24 h following MCAO, lipid peroxidation was assessed by measurement of its byproduct, 
MDA (Figure 3.5A).  No significant difference was found between sham and MCAO rats.  
Apocynin treatment significantly decreased MDA concentration in aged rats as compared to 
aged sham rats. 
 Protein oxidation was measured by assessment of protein carbonyl content (Figure 5B).  
In aged rats, apocynin treatment significantly increased protein carbonyl content in the 
ipsilateral (13±1 nmol/mg) and contralateral (11±2 nmol/mg) hemispheres as compared to aged 
sham rats (6±1 nmol/mg).   Aged rats showed significantly higher protein carbonyl content in the 
contralateral hemisphere post MCAO (11±2 nmol/mg) than aged sham rats (6±1 nmol/mg).  
When treated with apocynin there was a significant increase in protein carbonyl content in 
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young adult rats in both the ipsilateral (10±0.5 nmol/mg and 7±1 nmol/mg, respectively) and 
contralateral (8±1 nmol/mg and 6±0.7 nmol/mg, respectively) hemispheres as compared to 
young adult vehicle-treated rats.  At 24 h following MCAO, young adult vehicle-treated rats 
showed no change in protein carbonyl content as compared to sham rats.   
DISCUSSION 
The primary finding of this study was that inhibition of the NOX2 isoform of NADPH oxidase 
prior to MCAO elicited distinctly different brain injuries between young adult and aged rats.  We 
report, for the first time, that treatment with apocynin prior to MCAO in aged rats resulted in 
increased mortality at 24 h with no improvement in total or regional infarct volume, edema 
formation, or functional outcome.  We showed that at 24 h following MCAO, both ipsilateral and 
contralateral hemispheres of aged rats had increased BBB permeability to sucrose (342 Da) 
and apocynin treatment did not improve BBB functional integrity.  Often in stroke studies 
utilizing young animals, the contralateral hemisphere is either ignored or considered control.  
However, previous clinical studies have observed changes in the contralateral hemisphere 
following stroke (Carey et al., 2002; Blank et al., 2003).  In addition to changes in BBB 
permeability in the contralateral hemisphere, significant changes in catalase activity, GPx 
activity, and protein carbonyl content after MCAO were found.  This study, in correlation with 
others (Buga et al., 2008; Carey et al., 2002; Blank et al., 2003), highlights a potential role for 
the contralateral hemisphere as a compensatory mechanism following stroke.  Utilizing aged 
rodents in stroke models provides a unique opportunity to gain a better understanding of 
changes in the contralateral hemisphere following stroke.  
 Our study confirmed the findings of previous studies that in young adult rats, NOX2 
inhibition with apocynin prior to MCAO significantly improved total stroke volume and functional 
outcome.  We demonstrated that much of the improvement in brain injury in young adult rats 
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following MCAO was due to improved striatal infarct volume, lessened edema formation, and 
decreased BBB disruption.  Understanding the effects of ischemic brain injury in reproductively 
senescent females is an understudied yet important area of research as females have an 
increased overall stroke burden (Lloyd-Jones et al., 2009).  Recent studies indicate that gender 
plays a role in some mechanistic pathways following brain injury and recovery after stroke (De 
Silva et al., 2009; McCullough LD et al., 2005).  Our current results argue against gender-
related differences in NADPH oxidase activity, as results obtained from young adult female rats 
in our study were comparable to young adult male rats used in previous studies (Tang et al., 
2007;Tang et al., 2008;Yenari MA et al., 2006;Kahles T et al., 2007); however, further 
investigation will need to be done to ascertain if these findings hold true in aged rats.    
 The decreased SOD and GPx activity observed in aged rats supports the “free radical 
theory of aging”, which contends that age-related diseases result from increased generation of 
reactive oxygen species (Harman D, 1994) and decreased antioxidant enzyme activity (Azhar S 
et al., 1995; Abete P et al., 1999).  However, in concurrence with other studies (Meng et al., 
2007; Goto et al., 1999), catalase activity and protein oxidation were unchanged due to the 
aging process.  The brain, having a high metabolic rate and lack of metabolic reserves, 
possesses an increased concentration of mitochondria compared to other organs.  Thus the 
brain is more resistant to lipid peroxidation (Meyer et al., 2004), perhaps due to break down of 
MDA by mitochondrial aldehyde dehydrogenase (Siu and Draper, 1982).  Hypoxia and brain 
injury show elevated MDA, however, this increase is only seen at early time points, between 1 
and 3 h (Lo W et al., 2007; Wang Q et al., 2006; Pantke et al., 1999).  Due to the early formation 
and stability of protein carbonyl (Pantke et al., 1999), we propose that it is a better indicator than 
TBARS of oxidative damage in the brain at 24h after MCAO. 
Inhibition of NOX2 with apocynin has recently gained momentum as a therapeutic option 
for treatment of acute ischemic stroke (Tang et al., 2007; Wang Q et al., 2006; Kahles T et al., 
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2007) as several studies demonstrate that administration of apocynin (5-50 mg/kg; i.p.) in young 
rodents prior to MCAO attenuated superoxide production, infarct volume (Tang et al., 2007), 
neuronal death, activated microglia (Wang Q et al., 2006) and edema formation (Kahles T et al., 
2007).  Interestingly though, route of administration may play a role in apocynin toxicity as a 
recent study reported that when apocynin (5 mg/kg) was administered intravenously prior to 
MCAO, rodents exhibited larger cerebral hemorrhages in both hemispheres and increased 
mortality (Tang et al., 2008).  These opposing findings suggest that the activation, mechanism 
of action, and toxicity of apocynin are still poorly understood and further studies are necessary, 
especially before any therapeutic use of NOX2 inhibition is pursued in clinical trials.  
In this study, young adult apocynin-treated rats exhibited decreased GPx activity and 
increased protein oxidation after MCAO and reperfusion, possibly as a consequence of 
unactivated apocynin, which acts as a pro-oxidant by decreasing the glutathione to glutathione 
disulfide ratio (Riganti et al., 2006).  Unactivated apocynin promotes hydrogen peroxide 
production and increases protein carbonyl formation (Riganti et al., 2006; Ciolino and Levine, 
1997).  Unactivated apocynin must be activated to inhibit NOX2 (Stefanska and Pawliczak, 
2008).  Activation of apocynin by myeloperoxidase (MPO) forms an apocynin dimer, which 
prevents recruitment of the cytosolic proteins and thereby inhibits NADPH oxidase activation 
(Stefanska and Pawliczak, 2008).  In pathologic inflammatory conditions MPO is elevated 
(Tsimikas, 2008). In particular, aged animals exhibit exacerbated inflammatory cell infiltration 
(DiNapoli VA et al., 2008) and worsened stroke volume which produces increased MPO 
expression (Romanos et al., 2007).  The positive correlation between MPO expression and 
apocynin activation suggests enhanced NOX2 inhibition with age.  Data gathered from young 
animals suggest that increased NOX2 inhibition results in a favorable outcome.  In direct 
contrast, our data show that aged rats exhibit exacerbated edema formation and increased 
64 
 
mortality.  We conclude that inhibition of NOX2 with apocynin exacerbates stroke injury in the 
aged rat and would be a poor choice for clinical treatment of stroke.  
Results from models utilizing aged animals are increasingly divergent from those in 
young adult animals.  Evidence collected from aged animal models (DiNapoli VA et al., 2008; 
DiNapoli VA et al., 2006; Badan I et al., 2003; Popa-Wagner et al., 2007; Schroeder E et al., 
2003) suggests that, in addition to exacerbated brain injury and persistent functional deficit after 
stroke, changes are occurring in the contralateral hemisphere.  Disregarding the aging process 
in stroke research may be an important and yet overlooked mechanism resulting in failure to 






Figure 3.1: Functional Outcome was measured utilizing the modified Neurological Severity 
Score (mNSS).  Values are expressed as mean ± SEM (n=42).  Statistical significance was 
determined as * p < 0.05 as compared to vehicle treated MCAO young adult rats and # p < 0.05 






Figure 3.2: TTC stained brain sections were used to calculate (A) cortical, (B) striatal, and (C) 
total stroke volume and (D) edema formation at 24 h following MCAO in vehicle and apocynin-
treated young adult and aged rats.  Bars represent mean ± S.E. (n=6).  Statistical significance 
was set at *p<0.05 compared to vehicle-treated young adult rats, #p<0.05 as compared to 




Figure 3.3.  At 24 h following MCAO, (A) in situ brain perfusion using [14C]sucrose (342 Da) was 
used to determine the degree of BBB permeability and (B) the effect of apocynin treatment on 
changes in BBB permeability in young adult and aged rats.  Brains were separated into infarcted 
and non-infarcted hemispheres.  Bars represent mean ± S.E. (n=6).  Statistical significance was 
set at *p<0.05 compared to vehicle-treated age-matched sham, #p<0.05 compared to 
respective hemisphere of the vehicle-treated young adult MCAO rats, ‡p<0.05 compared to the 
respective non-infarct hemisphere, and †p<0.05 as compared to apocynin-treated young adult 





Figure 3.4.  (A) Superoxide dismutase (SOD), (B) glutathione peroxidase (GPx), and (C) 
catalase (CAT) activities were spectrophotometrically measured in infarcted and non-infarcted 
hemispheres at 24 h following MCAO in vehicle and apocynin-treated young adult and aged 
rats.  Bars represent mean ± S.E. (n=6).  Statistical significance was set at *p<0.05 compared to 
age-matched sham, #p<0.05 compared to vehicle-treated young adult MCAO rats, ‡p<0.05 
compared to respective non-infarct hemisphere, †p<0.05 compared to apocynin-treated young 
adult rats and §p<0.05 compared to respective young adult group using three-way ANOVA with 





Figure 3.5: Downstream products of lipid peroxidation (A) malondialdehyde (MDA) and (B) 
protein carbonyl were spectrophotometrically measured to assess the effect of apocynin 
treatment on oxidative stress at 24 h following MCAO in young adult and aged rats.  Brains 
were separated into infarcted and non-infarcted hemispheres.  Bars represent mean ± S.E. 
(n=6).  Statistical significance was set at *p<0.05 compared to age-matched sham, #p<0.05 
compared to vehicle-treated young adult MCAO,  and §p<0.05 compared to respective young 














NADPH oxidases (NOX) are a family of enzymes that play a role in the aging process, 
progression of atherosclerosis, and inflammatory response. However, the role of NOX isoforms 
during stroke-related ischemia and reperfusion in aged rats has yet to be elucidated. In this 
study, middle cerebral artery occlusion (MCAO) with tissue plasminogen activator (tPA) was 
used to assess time-dependent changes in NOX1, NOX2, NOX4, and catalytic subunits 
P22PHOX and P47PHOX in aged female rats. Real time (RT) PCR was used to determine 
transcriptional regulation of NOX isoforms 2 and 24 h post MCAO and reperfusion. NOX1 
transcriptional regulation was decreased in the contralateral hemisphere 24 h after MCAO. 
Downregulation of NOX4 24 h after MCAO and reperfusion was found in the ipsilateral cortex. 
NOX2 was upregulated at 24 h after stroke and reperfusion, a finding consistent with young 
animals. Catyaltic subunit P22PHOX , binds to all NOX isoforms, and is upregulated at 24 h. 
Post-ischemia molecular mechanisms in aged rats are poorly understood, which may explain 





Stroke is a disease of the elderly, yet most preclinical studies have been conducted in young 
rodents.  Evidence suggests that altered NOX expression may play a role in the aging process 
(Krause, 2007; Geiszt et al., 2000; Park L et al., 2007).  NOX2 containing NADPH oxidases are 
a damaging source of reactive oxygen species during the aging process (Park L et al., 2007; 
Hamilton CA et al., 2001) and progression of ischemic damage (Walder et al., 1997; Wang Q et 
al., 2006).  Several studies demonstrate that inhibition of NOX2 with apocynin in young rodents 
prior to MCAO attenuated superoxide production, infarct volume (Tang et al., 2007), neuronal 
death, activated microglia (Wang Q et al., 2006) and edema formation(Kahles T et al., 2007).  In 
contrast, inhibition of NOX2 with apocynin in aged animals caused increased edema and 
mortality 24 h after middle cerebral artery occlusion (MCAO) with tissue plasminogen activator 
(tPA) reperfusion (Kelly et al., 2009).      
Several isoforms of NADPH oxidases are expressed in vascular cells.  While NOX2 is 
widely considered the predominant isoform, it is the least expressed isoform in the brain 
vasculature.  In the brain vasculature, NADPH oxidase isoform expression varies with NOX1 
being the most abundant, followed by NOX4 and lastly NOX2 (Ago et al., 2005).  As NOX1 and 
NOX4 have yet to be extensively studied, their roles are not yet fully understood.  After cerebral 
ischemia, NOX1 knockout mice had greater cortical infarct volume when compared to wild type 
mice (Jackman et al., 2009), suggesting that NOX1 may play a neuroprotective role in stroke 
progression.  Following ischemic stroke and reperfusion, expression of NOX4 is increased at 
early time points but after reperfusion returns to baseline levels (McCann SK et al., 2008), 
possibly impacting reperfusion injury.  The relationship between NOX isoform expression, 
ischemia and age has yet to be determined.  This study utilized MCAO with tPA reperfusion in 





Female Sprague-Dawley rats aged 18-20 months (275-350 g) were received from Harlan 
(Indianapolis, IN) and housed under natural light/dark conditions with food and water available 
ad libitum.  Procedures involving animals abided by the West Virginia University Animal Care 
and Use Committee.  Rats were anesthetized with 2% isoflurane (Webster Veterinary).  Rats 
underwent MCAO for 2 h followed by tPA (Genentech; San Francisco, CA)-induced reperfusion 
as previously described (DiNapoli VA et al., 2006).  Briefly, a micro-catheter was inserted into 
the internal carotid artery (ICA) and advanced until its tip occluded the ipsilateral MCA.  This 
mechanical occlusion was verified by laser Doppler (LD-CBF) monitoring of the cerebral blood 
flow in the MCA perfusion territory.  A 25 mm fibrin-rich, autologous blood clot was then injected 
directly into the MCA.  Cerebral blood flow (CBF) was monitored continuously.  After 2 h of 
ischemia, tPA (5 mg/kg) was administered via the femoral vein, and restoration of blood flow 
through the MCA was verified by LD-CBF.  Ischemia was defined as a perfusion drop across the 
MCA territory of >80% as determined by laser Doppler and successful reperfusion was denoted 
as a return to >80% of baseline perfusion rate by 30 min after tPA administration.  Animals not 
meeting this criteria were excluded from analysis.  
Microvessel Isolation  
At 2 and 24 h after MCAO rats were anesthetized with ketamine (90 mg/kg; i.p.) and 
xylazine (5 mg/kg; i.p.) and transcardially perfused with 0.9% saline.  Brains were 
removed and microvessel isolations were performed as previously described (VanGilder 
et al., 2009).  Briefly, brains were separated into ipsilateral and contralateral 
hemispheres and the meninges and choroid plexus removed.  Samples of cortex (0.75 
g) and striatum (0.75 g) were taken for RNA and protein extraction.  The remaining 
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cortex was homogenized in 2 ml microvessel isolation buffer (MVI1; 103 mM NaCl; 
4.7mM KCl; 2.5 mM KH2PO4; 1.2 mM MgSO4; 15 mM HEPES; 2.5 mM NaHCO3; 10 mM 
D-glucose; 1 mM Na pyruvate; 10 g/l dextran (64,000 Da)) with protease inhibitor 
cocktail (PIC; 1:1000).  Dextran (26%) was added and the homogenate was centrifuged 
at 4°C for 10 min at 5,800 x g.  The supernatant was aspirated and the pellet 
resuspended in 2.5 ml of a second microvessel isolation buffer (MVI2; 103 mM NaCl; 
4.7 mM KCl; 2.5 mM CaCl2; 1.2 mM KH2PO4; 1.2 mM MgSO4; 15 mM HEPES).  The 
homogenate was then filtered through a 100 μm filter and centrifuged at 4°C for 5 min at 
5,800 x g.  The supernatant was decanted and the microvessel pellet used for RNA 
extraction. 
Real Time – Polymerase Chain Reaction (RT-PCR) 
Total RNA was isolated from cerebral microvessels (n=4) using TriReagent®. 
Concentration of RNA was determined and only considered for use if A260/A280 was 
≥1.80.  Total RNA was reverse transcribed into cDNA using a 20 µl reaction. RT-PCR 
analyses of NOX1, NOX2, NOX4, p22phox, and p47phox using a StepOne™ detection 
system (Applied Biosystems; Foster City, CA) in combination with TaqMan® chemistry. 
Specific primers and dual labeled internal (FAM/TAMRA) probe sets were used 
according to manufacturer’s recommendation (Applied Biosystems).  All PCR 
amplifications were run in a 20 µl reaction volume consisting of 1µl cDNA.  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as control to 
normalize for differences in amount of cDNA added to reactions.  Negative controls 
were monitored simultaneously within each run.  Thermocycling conditions were set to 
holding stage at 50° C for 2 min and 95°C for 10 min and 40 cycles of 95° C for 15 s 
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and 60° C for 1 min.  According to manufacturer’s instructions, relative quantification of 
mRNA transcripts was carried out using the comparative threshold (ΔΔCT) method.    
Statistics 
Data for mRNA are presented as ΔΔCT and was compared by one-way (ANOVA) with Tukey’s 
post hoc analysis.  Statistical significance was set at p<0.05.    
Results 
RT-PCR analysis of NOX1 was performed at 2 h after MCAO and 24 h after MCAO and 
reperfusion (Figure 4.1).  NOX1 transcription was decreased 24 h after MCAO and reperfusion 
in the contralateral hemisphere of the cortex (1.7 fold; p=0.05) and striatum (2.3 fold; p=0.025) 
as compared to aged matched sham rats. 
 RT-PCR analysis of NOX4 was performed at 2 h after MCAO and 24 h after MCAO and 
reperfusion (Figure 4.2).  Transcription of NOX4 was decreased 2 fold in the ipsilateral 
hemisphere of the cortex at 24 h post-MCAO and reperfusion (p=0.006) as compared to aged 
matched sham rats. 
 At 2 and 24 h after MCAO and reperfusion RT-PCR analysis of NOX2 (Figure 4.3) 
revealed significant increases in transcription after 24 h in the ipsilateral hemisphere.  In the 
cerebral microvessels of the ipsilateral hemisphere NOX2 transcription was increased 4 fold as 
compared to aged matched sham rats (p=0.012).  NOX2 transcription was increased 3 fold in 
the ipsilateral hemisphere of the striatum (p=0.003) as compared to aged matched sham rats. 
 The transcription of the P22PHOX membrane bound subunit of NADPH oxidase was 
measured by RT-PCR 2 and 24 h after MCAO and reperfusion (Figure 4.4).  In the ipsilateral 
hemisphere, transcription of P22PHOX was increased 2 fold in the cerebral microvessels 
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(p=0.05), 2.4 fold in the cortex (p=0.018), and 2.7 fold in the striatum (p=0.011) as compared to 
age matched sham rats. 
 Finally, P47PHOX transcription was measured by RT-PCR at 2 and 24 h after MCAO 
and reperfusion (figure 4.5).  In the contralateral hemisphere at 2 h, P47PHOX transcription was 
decreased 2.4 fold (p=0.01) as compared to age matched sham rats. 
Discussion 
The primary finding of this study is that although the NOX2 isoform and P22PHOX subunit are 
increased at 24 h post-MCAO and reperfusion, conversely the NOX4 and NOX1 isoforms 
exhibit either unchanged or decreased transcription at both time points studied. 
Without selective inhibitors of NOX1, its direct effect on stroke outcome is poorly 
understood.  One study using NOX1 knockout mice found that cortical infarct volume was four 
fold greater in young adult NOX1 knockout mice when compared to wild type mice with 30 min 
MCAO and 23.5 h reperfusion (Jackman et al., 2009).  As NOX1 may play a potentially 
beneficial role in stroke outcome, the decreased mRNA expression found in the cortex and 
striatum of the contralateral hemisphere of aged rats could explain the greater stroke damage 
found in aged rats after MCAO and reperfusion.   
In young adult animals NOX4 mRNA is increased at 24 h after permanent cerebral 
ischemia peaking between 7 and 15 days in the ischemic hemisphere (Vallet P et al., 2005).  In 
contrast, a model of MCAO and reperfusion found increased NOX4 mRNA expression as early 
as 6 h after MCAO with a return to baseline within 24 h (McCann SK et al., 2008), indicating a 
clear difference in NOX4 expression depending on reperfusion.  Interestingly, 
immunohistochemical analysis of NOX4 at 7 days post-MCAO revealed the location of the 
NOX4 expression to be in the new capillaries (Vallet P et al., 2005).  There was a trend towards 
increased NOX4 expression in the ipsilateral cortex at 2 h after MCAO and significantly 
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decreased expression at 24 h indicating a similar sequence of NOX4 regulation after MCAO as 
Vallet et al., 2005.  This suggests that age does not play a significant role in transcriptional 
regulation of NOX4 after MCAO and reperfusion.   
Tumor necrosis factor alpha (TNFα) has been shown to increase activity of NOX4 
(Basuroy et al., 2008;Jung Y et al., 2008;Chenevier-Gobeaux et al., 2006).  After MCAO, TNFα 
is increased as early as 1 h (Wang et al., 1994) and progressing out to several days and even 
weeks in humans (Sairanen et al., 2001).  TNFα quickly activates NOX4 suggesting post-
translational mechanism of the increased activity (Basuroy et al., 2008).  As TNFα expression is 
increased in aged animals as compared to young adult animals after stroke (DiNapoli, 
unpublished data) it is possible that NOX4 activity but not translation is increased in aged 
animals after MCAO and reperfusion.   
Increased mRNA expression of NOX2 was found in both the ipsilateral cortex and 
striatum of young adult animals 24 h post MCAO and reperfusion (McCann SK et al., 2008).  In 
mice with dysfunctional NOX2 transient focal ischemia resulted in decreased infarct volume 
than wild type mice (Walder et al., 1997).  Age has been shown to increase superoxide 
production by NOX2 causing impaired endothelium dependent relaxation and functional 
hyperemia (park L et al., 2007).  Inhibition of NOX2 with apocynin has recently gained 
momentum as a therapeutic option for treatment of acute ischemic stroke (Tang et al., 2007; 
Wang Q et al., 2006; Kahles T et al., 2007) as studies demonstrate that administration of 
apocynin (5-50 mg/kg; i.p.) in young rodents prior to MCAO, attenuated superoxide production, 
infarct volume (Tang et al., 2007), neuronal death, activation of microglia (Wang Q et al., 2006) 
and edema formation (Kahles T et al., 2007).  In direct contrast, our data show that aged rats 
exhibit exacerbated edema formation and increased mortality (Kelly et al., 2009).  The present 
study found increased NOX2 mRNA expression not only in the striatum, where most of the 
stroke damage if found, but also in the cerebral microvasculature.   
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P22PHOX is a membrane bound subunit of NADPH oxidase.  The NOX1, NOX2 and 
NOX4 isoforms of NADPH oxidase all bind to P22PHOX at the plasma membrane (Bedard K 
and Krause K, 2007;Clempus and Griendling, 2006).  NADPH oxidase activity has been linked 
to transcription changes in P22PHOX (Manea et al., 2007).  The present study found increased 
P22PHOX mRNA expression throughout the ipsilateral hemisphere in aged rats 24 h after 
MCAO and reperfusion.  This suggests that activity of NOX1, NOX2 and NOX4 may be 
increased as they all bind to P22PHOX.   
In conclusion, the direct affects of NOX1 and NOX4 activity after MCAO in aged animals 
need to be elucidated.  The present data suggest that NOX1 transcriptional regulation is altered 
with age, which may exacerbate stroke damage.  Transcriptional regulation of NOX2 and NOX4 
mimic that seen in young adult animals, however since the present study did not measure 
activity of these enzymes, post-transcriptional modification could play a role.  Changes in the 
contralateral hemisphere support recent evidence (Kelly et al., 2009; Buga et al., 2008; Carey et 
al., 2002; Blank et al., 2003) that investigation of changes in the contralateral hemisphere is 






Figure 4.1.  NOX1 mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was 
measured by real-time PCR.  Samples were taken from isolated microvessels (A and B), cortex 
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F) 




Figure 4.2.  NOX4 mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was 
measured by real-time PCR.  Samples were taken from isolated microvessels (A and B), cortex 
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F) 





Figure 4.3.  NOX2 mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was 
measured by real-time PCR.  Samples were taken from isolated microvessels (A and B), cortex 
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F) 





Figure 4.4.  P22POX mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was 
measured by real-time PCR.  Samples were taken from isolated microvessels (A and B), cortex 
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F) 





Figure 4.5.  P47PHOX mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was 
measured by real-time PCR.  Samples were taken from isolated microvessels (A and B), cortex 
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F) 
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